ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||||||||||||||||||||
trichloroethene
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
increases expression | ISO | 7 | 87,133,179 | 87,342,639 | RGD:6480464 | CTD | |
| G | ACADS | acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
decreases expression | ISO | 12 | 121,163,571 | 121,177,811 | RGD:6480464 | CTD | |
| G | ACADVL | acyl-CoA dehydrogenase, very long chain |
|
increases expression | ISO | 17 | 7,120,444 | 7,128,586 | RGD:6480464 | CTD | |
| G | ACOT1 | acyl-CoA thioesterase 1 |
|
increases expression | ISO | 14 | 74,003,928 | 74,010,498 | RGD:6480464 | CTD | |
| G | ACOT1 | acyl-CoA thioesterase 1 |
|
increases expression | ISO | 14 | 74,003,928 | 74,010,498 | RGD:6480464 | CTD | |
| G | ACOX1 | acyl-CoA oxidase 1, palmitoyl |
|
multiple interactions | ISO | 17 | 73,937,588 | 73,975,515 | RGD:6480464 | CTD | |
| G | ACOX1 | acyl-CoA oxidase 1, palmitoyl |
|
increases expression | ISO | 17 | 73,937,588 | 73,975,515 | RGD:6480464 | CTD | |
| G | ACOX2 | acyl-CoA oxidase 2, branched chain |
|
increases expression | ISO | 3 | 58,490,863 | 58,522,929 | RGD:6480464 | CTD | |
| G | ACP1 | acid phosphatase 1, soluble |
|
increases expression | ISO | 2 | 264,869 | 278,283 | RGD:6480464 | CTD | |
| G | ACSL1 | acyl-CoA synthetase long-chain family member 1 |
|
increases expression | ISO | 4 | 185,676,749 | 185,747,215 | RGD:6480464 | CTD | |
| G | ACTB | actin, beta |
|
increases expression | ISO | 7 | 5,566,779 | 5,570,232 | RGD:6480464 | CTD | |
| G | ACTC1 | actin, alpha, cardiac muscle 1 |
|
decreases expression | ISO | 15 | 35,080,297 | 35,087,927 | RGD:6480464 | CTD | |
| G | ACVR1C | activin A receptor, type IC |
|
multiple interactions | ISO | 2 | 158,383,279 | 158,485,399 | RGD:6480464 | CTD | |
| G | ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide |
|
increases expression | ISO | 4 | 100,044,832 | 100,065,449 | RGD:6480464 | CTD | |
| G | AES | amino-terminal enhancer of split |
|
decreases expression | ISO | 19 | 3,052,908 | 3,062,964 | RGD:6480464 | CTD | |
| G | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
decreases expression | ISO | 1 | 230,838,269 | 230,850,336 | RGD:6480464 | CTD | |
| G | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
decreases expression | ISO | 1 | 230,838,269 | 230,850,336 | RGD:6480464 | CTD | |
| G | AGTR2 | angiotensin II receptor, type 2 |
|
decreases expression | ISO | X | 115,301,958 | 115,306,225 | RGD:6480464 | CTD | |
| G | AGXT | alanine-glyoxylate aminotransferase |
|
increases expression | ISO | 2 | 241,808,162 | 241,818,536 | RGD:6480464 | CTD | |
| G | AHCY | adenosylhomocysteinase |
|
decreases expression | ISO | 20 | 32,868,071 | 32,899,608 | RGD:6480464 | CTD | |
| G | AHCYL1 | adenosylhomocysteinase-like 1 |
|
increases expression | ISO | 1 | 110,527,387 | 110,566,364 | RGD:6480464 | CTD | |
| G | AKR7A3 | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
|
increases expression | ISO | 1 | 19,609,057 | 19,615,280 | RGD:6480464 | CTD | |
| G | ALCAM | activated leukocyte cell adhesion molecule |
|
increases expression | ISO | 3 | 105,085,557 | 105,295,757 | RGD:6480464 | CTD | |
| G | ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 |
|
increases expression | ISO | 9 | 75,515,578 | 75,568,233 | RGD:6480464 | CTD | |
| G | ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 |
|
increases expression | ISO | 9 | 75,515,578 | 75,568,233 | RGD:6480464 | CTD | |
| G | ALDH1B1 | aldehyde dehydrogenase 1 family, member B1 |
|
increases expression | ISO | 9 | 38,392,661 | 38,398,662 | RGD:6480464 | CTD | |
| G | ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 |
|
increases expression | ISO | 3 | 125,822,404 | 125,900,029 | RGD:6480464 | CTD | |
| G | ALDH3A2 | aldehyde dehydrogenase 3 family, member A2 |
|
increases expression | ISO | 17 | 19,552,064 | 19,580,908 | RGD:6480464 | CTD | |
| G | AMBP | alpha-1-microglobulin/bikunin precursor |
|
multiple interactions | ISO | 9 | 116,822,407 | 116,840,752 | RGD:6480464 | CTD | |
| G | AMBP | alpha-1-microglobulin/bikunin precursor |
|
decreases expression | ISO | 9 | 116,822,407 | 116,840,752 | RGD:6480464 | CTD | |
| G | ANKRD40 | ankyrin repeat domain 40 |
|
increases expression | ISO | 17 | 48,770,551 | 48,785,270 | RGD:6480464 | CTD | |
| G | ANKRD46 | ankyrin repeat domain 46 |
|
decreases expression | ISO | 8 | 101,521,980 | 101,572,014 | RGD:6480464 | CTD | |
| G | ANPEP | alanyl (membrane) aminopeptidase |
|
multiple interactions | ISO | 15 | 90,328,126 | 90,358,072 | RGD:6480464 | CTD | |
| G | ANXA7 | annexin A7 |
|
increases expression | ISO | 10 | 75,135,189 | 75,173,841 | RGD:6480464 | CTD | |
| G | AP2S1 | adaptor-related protein complex 2, sigma 1 subunit |
|
decreases expression | ISO | 19 | 47,341,423 | 47,354,203 | RGD:6480464 | CTD | |
| G | APLP2 | amyloid beta (A4) precursor-like protein 2 |
|
decreases expression | ISO | 11 | 129,939,716 | 130,014,706 | RGD:6480464 | CTD | |
| G | APOA4 | apolipoprotein A-IV |
|
decreases expression | ISO | 11 | 116,691,418 | 116,694,011 | RGD:6480464 | CTD | |
| G | APOA4 | apolipoprotein A-IV |
|
increases expression | ISO | 11 | 116,691,418 | 116,694,011 | RGD:6480464 | CTD | |
| G | APOB | apolipoprotein B (including Ag(x) antigen) |
|
decreases expression | ISO | 2 | 21,224,301 | 21,266,945 | RGD:6480464 | CTD | |
| G | ARHGAP18 | Rho GTPase activating protein 18 |
|
multiple interactions | ISO | 6 | 129,898,240 | 130,031,370 | RGD:6480464 | CTD | |
| G | ARHGAP18 | Rho GTPase activating protein 18 |
|
multiple interactions | ISO | 6 | 129,898,240 | 130,031,370 | RGD:6480464 | CTD | |
| G | ARHGAP18 | Rho GTPase activating protein 18 |
|
multiple interactions | ISO | 6 | 129,898,240 | 130,031,370 | RGD:6480464 | CTD | |
| G | ASGR2 | asialoglycoprotein receptor 2 |
|
decreases expression | ISO | 17 | 7,004,641 | 7,018,130 | RGD:6480464 | CTD | |
| G | ASNS | asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression | ISO | 7 | 97,481,429 | 97,501,854 | RGD:6480464 | CTD | |
| G | ASS1 | argininosuccinate synthase 1 |
|
increases expression | ISO | 9 | 133,320,094 | 133,376,661 | RGD:6480464 | CTD | |
| G | ATF5 | activating transcription factor 5 |
|
multiple interactions | ISO | 19 | 50,431,959 | 50,437,193 | RGD:6480464 | CTD | |
| G | ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression | ISO | 1 | 116,915,795 | 116,947,396 | RGD:6480464 | CTD | |
| G | ATP2A2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression | ISO | 12 | 110,719,032 | 110,788,898 | RGD:6480464 | CTD | |
| G | ATP2A2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression | ISO | 12 | 110,719,032 | 110,788,898 | RGD:6480464 | CTD | |
| G | ATP2A2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression | ISO | 12 | 110,719,032 | 110,788,898 | RGD:6480464 | CTD | |
| G | ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 |
|
decreases expression | ISO | 3 | 130,569,369 | 130,735,556 | RGD:6480464 | CTD | |
| G | ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
|
increases expression | ISO | 18 | 43,664,110 | 43,684,199 | RGD:6480464 | CTD | |
| G | ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A |
|
increases expression | ISO | 3 | 113,465,866 | 113,530,905 | RGD:6480464 | CTD | |
| G | ATPIF1 | ATPase inhibitory factor 1 |
|
increases expression | ISO | 1 | 28,562,602 | 28,564,616 | RGD:6480464 | CTD | |
| G | AZGP1 | alpha-2-glycoprotein 1, zinc-binding |
|
increases expression | ISO | 7 | 99,564,350 | 99,573,735 | RGD:6480464 | CTD | |
| G | BAD | BCL2-associated agonist of cell death |
|
multiple interactions | ISO | 11 | 64,037,300 | 64,052,176 | RGD:6480464 | CTD | |
| G | BAD | BCL2-associated agonist of cell death |
|
increases expression | ISO | 11 | 64,037,300 | 64,052,176 | RGD:6480464 | CTD | |
| G | BASP1 | brain abundant, membrane attached signal protein 1 |
|
increases expression | ISO | 5 | 17,217,750 | 17,276,943 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
affects expression | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
increases expression | EXP | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAZ1B | bromodomain adjacent to zinc finger domain, 1B |
|
increases expression | ISO | 7 | 72,854,728 | 72,936,615 | RGD:6480464 | CTD | |
| G | BCAM | basal cell adhesion molecule (Lutheran blood group) |
|
affects expression | ISO | 19 | 45,312,316 | 45,324,678 | RGD:6480464 | CTD | |
| G | BCKDHA | branched chain keto acid dehydrogenase E1, alpha polypeptide |
|
decreases expression | ISO | 19 | 41,903,694 | 41,930,910 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
decreases expression | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
increases activity | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2A1 | BCL2-related protein A1 |
|
increases expression | EXP | 15 | 80,253,232 | 80,263,643 | RGD:6480464 | CTD | |
| G | BCL2L1 | BCL2-like 1 |
|
multiple interactions | ISO | 20 | 30,252,261 | 30,310,656 | RGD:6480464 | CTD | |
| G | BCL6 | B-cell CLL/lymphoma 6 |
|
increases expression | EXP | 3 | 187,439,165 | 187,463,513 | RGD:6480464 | CTD | |
| G | BDNF | brain-derived neurotrophic factor |
|
multiple interactions | ISO | 11 | 27,676,440 | 27,743,605 | RGD:6480464 | CTD | |
| G | BDNF | brain-derived neurotrophic factor |
|
decreases expression | ISO | 11 | 27,676,440 | 27,743,605 | RGD:6480464 | CTD | |
| G | BET1 | Bet1 golgi vesicular membrane trafficking protein |
|
multiple interactions | ISO | 7 | 93,621,000 | 93,633,690 | RGD:6480464 | CTD | |
| G | BGN | biglycan |
|
decreases expression | ISO | X | 152,760,347 | 152,775,004 | RGD:6480464 | CTD | |
| G | BHMT | betaine--homocysteine S-methyltransferase |
|
multiple interactions | ISO | 5 | 78,407,604 | 78,428,113 | RGD:6480464 | CTD | |
| G | BHMT | betaine--homocysteine S-methyltransferase |
|
increases expression | ISO | 5 | 78,407,604 | 78,428,113 | RGD:6480464 | CTD | |
| G | BIRC3 | baculoviral IAP repeat containing 3 |
|
increases expression | EXP | 11 | 102,188,181 | 102,210,134 | RGD:6480464 | CTD | |
| G | BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
|
multiple interactions | ISO | 10 | 133,781,204 | 133,795,435 | RGD:6480464 | CTD | |
| G | BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
|
increases expression | ISO | 10 | 133,781,204 | 133,795,435 | RGD:6480464 | CTD | |
| G | BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
|
multiple interactions | ISO | 10 | 133,781,204 | 133,795,435 | RGD:6480464 | CTD | |
| G | BSG | basigin (Ok blood group) |
|
multiple interactions | ISO | 19 | 571,277 | 583,493 | RGD:6480464 | CTD | |
| G | BTF3 | basic transcription factor 3 |
|
decreases expression | ISO | 5 | 72,794,250 | 72,801,448 | RGD:6480464 | CTD | |
| G | BTG1 | B-cell translocation gene 1, anti-proliferative |
|
increases expression | EXP | 12 | 92,534,054 | 92,539,673 | RGD:6480464 | CTD | |
| G | C1QB | complement component 1, q subcomponent, B chain |
|
decreases expression | ISO | 1 | 22,979,682 | 22,988,029 | RGD:6480464 | CTD | |
| G | C1QBP | complement component 1, q subcomponent binding protein |
|
increases expression | ISO | 17 | 5,336,099 | 5,342,471 | RGD:6480464 | CTD | |
| G | C3 | complement component 3 |
|
decreases expression | ISO | 19 | 6,677,846 | 6,720,662 | RGD:6480464 | CTD | |
| G | C4A | complement component 4A (Rodgers blood group) |
|
decreases expression | ISO | 6 | 31,949,834 | 31,970,457 | RGD:6480464 | CTD | |
| G | C4A | complement component 4A (Rodgers blood group) |
|
decreases expression | ISO | 6 | 31,949,834 | 31,970,457 | RGD:6480464 | CTD | |
| G | CALM1 | calmodulin 1 (phosphorylase kinase, delta) |
|
affects expression | ISO | 14 | 90,863,327 | 90,874,619 | RGD:6480464 | CTD | |
| G | CALR | calreticulin |
|
decreases expression | ISO | 19 | 13,049,414 | 13,055,304 | RGD:6480464 | CTD | |
| G | CANX | calnexin |
|
increases expression | ISO | 5 | 179,125,930 | 179,158,642 | RGD:6480464 | CTD | |
| G | CAPRIN1 | cell cycle associated protein 1 |
|
decreases expression | ISO | 11 | 34,073,230 | 34,124,157 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
increases activity | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CBLB | Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
increases expression | ISO | 3 | 105,377,109 | 105,587,887 | RGD:6480464 | CTD | |
| G | CBX6 | chromobox homolog 6 |
|
affects expression | ISO | 22 | 39,260,243 | 39,268,258 | RGD:6480464 | CTD | |
| G | CCBP2 | chemokine binding protein 2 |
|
multiple interactions | ISO | 3 | 42,850,964 | 42,908,775 | RGD:6480464 | CTD | |
| G | CCBP2 | chemokine binding protein 2 |
|
increases expression | ISO | 3 | 42,850,964 | 42,908,775 | RGD:6480464 | CTD | |
| G | CCL5 | chemokine (C-C motif) ligand 5 |
|
decreases expression | ISO | 17 | 34,198,495 | 34,207,377 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
decreases expression | ISO | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
increases expression | ISO | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND3 | cyclin D3 |
|
multiple interactions | ISO | 6 | 41,902,671 | 42,016,610 | RGD:6480464 | CTD | |
| G | CCND3 | cyclin D3 |
|
increases expression | ISO | 6 | 41,902,671 | 42,016,610 | RGD:6480464 | CTD | |
| G | CCNG1 | cyclin G1 |
|
increases expression | ISO | 5 | 162,864,577 | 162,872,022 | RGD:6480464 | CTD | |
| G | CCNG1 | cyclin G1 |
|
multiple interactions | ISO | 5 | 162,864,577 | 162,872,022 | RGD:6480464 | CTD | |
| G | CCNG1 | cyclin G1 |
|
increases expression | ISO | 5 | 162,864,577 | 162,872,022 | RGD:6480464 | CTD | |
| G | CCNI | cyclin I |
|
decreases expression | ISO | 4 | 77,969,165 | 77,997,125 | RGD:6480464 | CTD | |
| G | CCT3 | chaperonin containing TCP1, subunit 3 (gamma) |
|
increases expression | ISO | 1 | 156,278,752 | 156,308,206 | RGD:6480464 | CTD | |
| G | CCT6A | chaperonin containing TCP1, subunit 6A (zeta 1) |
|
multiple interactions | ISO | 7 | 56,119,378 | 56,131,682 | RGD:6480464 | CTD | |
| G | CCT6A | chaperonin containing TCP1, subunit 6A (zeta 1) |
|
increases expression | ISO | 7 | 56,119,378 | 56,131,682 | RGD:6480464 | CTD | |
| G | CD247 | CD247 molecule |
|
multiple interactions | ISO | 1 | 167,399,877 | 167,487,847 | RGD:6480464 | CTD | |
| G | CD27 | CD27 molecule |
|
decreases expression | EXP | 12 | 6,554,051 | 6,560,884 | RGD:6480464 | CTD | |
| G | CD36 | CD36 molecule (thrombospondin receptor) |
|
increases expression | ISO | 7 | 80,231,504 | 80,308,593 | RGD:6480464 | CTD | |
| G | CD37 | CD37 molecule |
|
decreases expression | ISO | 19 | 49,838,677 | 49,843,863 | RGD:6480464 | CTD | |
| G | CD38 | CD38 molecule |
|
increases expression | ISO | 4 | 15,779,931 | 15,850,706 | RGD:6480464 | CTD | |
| G | CD3E | CD3e molecule, epsilon (CD3-TCR complex) |
|
decreases expression | ISO | 11 | 118,175,295 | 118,186,890 | RGD:6480464 | CTD | |
| G | CD4 | CD4 molecule |
|
increases expression | ISO | 12 | 6,898,638 | 6,929,976 | RGD:6480464 | CTD | |
| G | CD47 | CD47 molecule |
|
multiple interactions | ISO | 3 | 107,761,941 | 107,809,935 | RGD:6480464 | CTD | |
| G | CD63 | CD63 molecule |
|
decreases expression | ISO | 12 | 56,119,227 | 56,123,457 | RGD:6480464 | CTD | |
| G | CD63 | CD63 molecule |
|
multiple interactions | ISO | 12 | 56,119,227 | 56,123,457 | RGD:6480464 | CTD | |
| G | CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain |
|
decreases expression | ISO | 5 | 149,781,200 | 149,792,499 | RGD:6480464 | CTD | |
| G | CD8A | CD8a molecule |
|
increases expression | ISO | 2 | 87,011,728 | 87,035,519 | RGD:6480464 | CTD | |
| G | CD9 | CD9 molecule |
|
decreases expression | ISO | 12 | 6,309,482 | 6,347,437 | RGD:6480464 | CTD | |
| G | CDC25B | cell division cycle 25B |
|
affects expression | ISO | 20 | 3,776,401 | 3,786,762 | RGD:6480464 | CTD | |
| G | CDC34 | cell division cycle 34 |
|
affects expression | ISO | 19 | 531,733 | 542,087 | RGD:6480464 | CTD | |
| G | CDH17 | cadherin 17, LI cadherin (liver-intestine) |
|
decreases expression | ISO | 8 | 95,139,394 | 95,229,531 | RGD:6480464 | CTD | |
| G | CDK1 | cyclin-dependent kinase 1 |
|
increases expression | ISO | 10 | 62,538,089 | 62,554,610 | RGD:6480464 | CTD | |
| G | CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
increases expression | ISO | 17 | 30,814,105 | 30,818,271 | RGD:6480464 | CTD | |
| G | CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
multiple interactions | ISO | 17 | 30,814,105 | 30,818,271 | RGD:6480464 | CTD | |
| G | CDK6 | cyclin-dependent kinase 6 |
|
increases expression | ISO | 7 | 92,234,235 | 92,465,941 | RGD:6480464 | CTD | |
| G | CDK6 | cyclin-dependent kinase 6 |
|
multiple interactions | ISO | 7 | 92,234,235 | 92,465,941 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
decreases expression | ISO | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN2D | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
|
increases expression | ISO | 19 | 10,677,138 | 10,679,655 | RGD:6480464 | CTD | |
| G | CEACAM21 | carcinoembryonic antigen-related cell adhesion molecule 21 |
|
decreases expression | ISO | 19 | 42,082,531 | 42,093,197 | RGD:6480464 | CTD | |
| G | CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression | ISO | 20 | 48,807,120 | 48,809,227 | RGD:6480464 | CTD | |
| G | CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
|
decreases expression | ISO | 20 | 48,807,120 | 48,809,227 | RGD:6480464 | CTD | |
| G | CEP170 | centrosomal protein 170kDa |
|
increases expression | EXP | 1 | 243,287,730 | 243,418,708 | RGD:6480464 | CTD | |
| G | CFL2 | cofilin 2 (muscle) |
|
decreases expression | ISO | 14 | 35,179,588 | 35,184,029 | RGD:6480464 | CTD | |
| G | CFLAR | CASP8 and FADD-like apoptosis regulator |
|
decreases expression | ISO | 2 | 201,980,877 | 202,037,411 | RGD:6480464 | CTD | |
| G | CHD1 | chromodomain helicase DNA binding protein 1 |
|
increases expression | ISO | 5 | 98,190,908 | 98,262,238 | RGD:6480464 | CTD | |
| G | CHD4 | chromodomain helicase DNA binding protein 4 |
|
increases expression | ISO | 12 | 6,679,248 | 6,716,551 | RGD:6480464 | CTD | |
| G | CHN2 | chimerin 2 |
|
increases expression | ISO | 7 | 29,234,121 | 29,553,944 | RGD:6480464 | CTD | |
| G | CHN2 | chimerin 2 |
|
increases expression | ISO | 7 | 29,234,121 | 29,553,944 | RGD:6480464 | CTD | |
| G | CHP1 | calcineurin-like EF-hand protein 1 |
|
multiple interactions | ISO | 15 | 41,523,437 | 41,574,085 | RGD:6480464 | CTD | |
| G | CIDEA | cell death-inducing DFFA-like effector a |
|
increases expression | ISO | 18 | 12,254,318 | 12,277,594 | RGD:6480464 | CTD | |
| G | CIITA | class II, major histocompatibility complex, transactivator |
|
increases expression | ISO | 16 | 10,971,055 | 11,018,840 | RGD:6480464 | CTD | |
| G | CIRBP | cold inducible RNA binding protein |
|
decreases expression | ISO | 19 | 1,269,267 | 1,274,809 | RGD:6480464 | CTD | |
| G | CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions | ISO | 6 | 139,693,392 | 139,695,787 | RGD:6480464 | CTD | |
| G | CKMT1B | creatine kinase, mitochondrial 1B |
|
affects expression | ISO | 15 | 43,885,252 | 43,891,604 | RGD:6480464 | CTD | |
| G | CLCN3 | chloride channel, voltage-sensitive 3 |
|
increases expression | ISO | 4 | 170,541,672 | 170,644,338 | RGD:6480464 | CTD | |
| G | CLEC4F | C-type lectin domain family 4, member F |
|
decreases expression | ISO | 2 | 71,035,775 | 71,047,732 | RGD:6480464 | CTD | |
| G | CLIC4 | chloride intracellular channel 4 |
|
decreases expression | ISO | 1 | 25,071,760 | 25,170,815 | RGD:6480464 | CTD | |
| G | CLPTM1L | CLPTM1-like |
|
increases expression | ISO | 5 | 1,317,999 | 1,345,002 | RGD:6480464 | CTD | |
| G | CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 |
|
affects expression | ISO | 16 | 66,648,653 | 66,730,610 | RGD:6480464 | CTD | |
| G | COL1A1 | collagen, type I, alpha 1 |
|
multiple interactions | ISO | 17 | 48,261,457 | 48,279,000 | RGD:6480464 | CTD | |
| G | COL1A2 | collagen, type I, alpha 2 |
|
increases expression | ISO | 7 | 94,023,873 | 94,060,544 | RGD:6480464 | CTD | |
| G | COL3A1 | collagen, type III, alpha 1 |
|
multiple interactions | ISO | 2 | 189,839,099 | 189,877,472 | RGD:6480464 | CTD | |
| G | COMT | catechol-O-methyltransferase |
|
decreases expression | ISO | 22 | 19,929,263 | 19,957,498 | RGD:6480464 | CTD | |
| G | COPB2 | coatomer protein complex, subunit beta 2 (beta prime) |
|
increases expression | ISO | 3 | 139,076,433 | 139,108,522 | RGD:6480464 | CTD | |
| G | COX5A | cytochrome c oxidase subunit Va |
|
decreases expression | ISO | 15 | 75,212,616 | 75,230,495 | RGD:6480464 | CTD | |
| G | COX6B2 | cytochrome c oxidase subunit VIb polypeptide 2 (testis) |
|
decreases expression | ISO | 19 | 55,861,070 | 55,866,182 | RGD:6480464 | CTD | |
| G | CPB2 | carboxypeptidase B2 (plasma) |
|
increases expression | ISO | 13 | 46,627,322 | 46,679,211 | RGD:6480464 | CTD | |
| G | CPT1A | carnitine palmitoyltransferase 1A (liver) |
|
increases expression | ISO | 11 | 68,522,088 | 68,609,399 | RGD:6480464 | CTD | |
| G | CPT2 | carnitine palmitoyltransferase 2 |
|
increases expression | ISO | 1 | 53,662,101 | 53,679,869 | RGD:6480464 | CTD | |
| G | CRAT | carnitine O-acetyltransferase |
|
affects expression | ISO | 9 | 131,857,073 | 131,873,070 | RGD:6480464 | CTD | |
| G | CREG1 | cellular repressor of E1A-stimulated genes 1 |
|
increases expression | ISO | 1 | 167,510,250 | 167,523,056 | RGD:6480464 | CTD | |
| G | CREM | cAMP responsive element modulator |
|
decreases expression | ISO | 10 | 35,415,769 | 35,501,886 | RGD:6480464 | CTD | |
| G | CRIP2 | cysteine-rich protein 2 |
|
decreases expression | ISO | 14 | 105,939,275 | 105,946,507 | RGD:6480464 | CTD | |
| G | CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
multiple interactions | ISO | 22 | 21,271,714 | 21,308,037 | RGD:6480464 | CTD | |
| G | CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
increases expression | ISO | 22 | 21,271,714 | 21,308,037 | RGD:6480464 | CTD | |
| G | CSF1 | colony stimulating factor 1 (macrophage) |
|
increases expression | ISO | 1 | 110,453,233 | 110,473,616 | RGD:6480464 | CTD | |
| G | CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
|
multiple interactions | ISO | X Y |
1,387,693 1,337,693 |
1,428,828 1,378,828 |
RGD:6480464 | CTD | |
| G | CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
|
increases expression | ISO | X Y |
1,387,693 1,337,693 |
1,428,828 1,378,828 |
RGD:6480464 | CTD | |
| G | CSNK2A1 | casein kinase 2, alpha 1 polypeptide |
|
multiple interactions | ISO | 20 | 463,338 | 524,482 | RGD:6480464 | CTD | |
| G | CTH | cystathionase (cystathionine gamma-lyase) |
|
increases expression | EXP | 1 | 70,876,901 | 70,905,534 | RGD:6480464 | CTD | |
| G | CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa |
|
decreases expression | ISO | 3 | 41,240,942 | 41,281,939 | RGD:6480464 | CTD | |
| G | CTSB | cathepsin B |
|
multiple interactions | ISO | 8 | 11,700,033 | 11,725,646 | RGD:6480464 | CTD | |
| G | CTSL1 | cathepsin L1 |
|
increases expression | ISO | 9 | 90,340,974 | 90,346,384 | RGD:6480464 | CTD | |
| G | CUL1 | cullin 1 |
|
increases expression | ISO | 7 | 148,395,933 | 148,498,202 | RGD:6480464 | CTD | |
| G | CX3CR1 | chemokine (C-X3-C motif) receptor 1 |
|
multiple interactions | ISO | 3 | 39,304,985 | 39,323,226 | RGD:6480464 | CTD | |
| G | CXCR2 | chemokine (C-X-C motif) receptor 2 |
|
increases expression | ISO | 2 | 218,990,013 | 219,001,976 | RGD:6480464 | CTD | |
| G | CXCR4 | chemokine (C-X-C motif) receptor 4 |
|
increases expression | EXP | 2 | 136,871,919 | 136,875,725 | RGD:6480464 | CTD | |
| G | CYB5A | cytochrome b5 type A (microsomal) |
|
increases expression | ISO | 18 | 71,920,527 | 71,959,251 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases response to substance | EXP | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
increases expression | ISO | 15 | 75,041,184 | 75,048,941 | RGD:6480464 | CTD | |
| G | CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 |
|
decreases expression | EXP | 2 | 38,294,746 | 38,303,323 | RGD:6480464 | CTD | |
| G | CYP2A | cytochrome P450, family 2, subfamily A | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases metabolic processing | EXP | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases activity | EXP | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
affects metabolic processing | EXP | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases metabolic processing | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
multiple interactions | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases expression | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
multiple interactions | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases metabolic processing | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
affects metabolic processing | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases response to substance | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
multiple interactions | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases activity | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases response to substance | EXP | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases metabolic processing | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases metabolic processing | EXP | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
affects metabolic processing | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2F1 | cytochrome P450, family 2, subfamily F, polypeptide 1 |
|
decreases expression | ISO | 19 | 41,620,353 | 41,634,281 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
multiple interactions | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4V2 | cytochrome P450, family 4, subfamily V, polypeptide 2 |
|
decreases expression | ISO | 4 | 187,112,674 | 187,134,617 | RGD:6480464 | CTD | |
| G | CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 |
|
increases expression | ISO | 8 | 59,402,737 | 59,412,720 | RGD:6480464 | CTD | |
| G | DAD1 | defender against cell death 1 |
|
increases expression | ISO | 14 | 23,033,807 | 23,058,143 | RGD:6480464 | CTD | |
| G | DAD1 | defender against cell death 1 |
|
multiple interactions | ISO | 14 | 23,033,807 | 23,058,143 | RGD:6480464 | CTD | |
| G | DCN | decorin |
|
increases expression | ISO | 12 | 91,539,035 | 91,576,806 | RGD:6480464 | CTD | |
| G | DDN | dendrin |
|
affects expression | ISO | 12 | 49,388,933 | 49,393,088 | RGD:6480464 | CTD | |
| G | DDX24 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 |
|
decreases expression | ISO | 14 | 94,517,268 | 94,547,558 | RGD:6480464 | CTD | |
| G | DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked |
|
decreases expression | ISO | X | 41,192,651 | 41,209,527 | RGD:6480464 | CTD | |
| G | DDX6 | DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
|
decreases expression | ISO | 11 | 118,618,472 | 118,661,972 | RGD:6480464 | CTD | |
| G | DENND5A | DENN/MADD domain containing 5A |
|
increases expression | EXP | 11 | 9,160,372 | 9,286,873 | RGD:6480464 | CTD | |
| G | DGAT1 | diacylglycerol O-acyltransferase 1 |
|
multiple interactions | ISO | 8 | 145,538,247 | 145,550,567 | RGD:6480464 | CTD | |
| G | DGAT1 | diacylglycerol O-acyltransferase 1 |
|
increases expression | ISO | 8 | 145,538,247 | 145,550,567 | RGD:6480464 | CTD | |
| G | DGAT2 | diacylglycerol O-acyltransferase 2 |
|
increases expression | ISO | 11 | 75,479,778 | 75,512,581 | RGD:6480464 | CTD | |
| G | DGAT2 | diacylglycerol O-acyltransferase 2 |
|
multiple interactions | ISO | 11 | 75,479,778 | 75,512,581 | RGD:6480464 | CTD | |
| G | DGAT2 | diacylglycerol O-acyltransferase 2 |
|
increases expression | ISO | 11 | 75,479,778 | 75,512,581 | RGD:6480464 | CTD | |
| G | DGCR2 | DiGeorge syndrome critical region gene 2 |
|
decreases expression | ISO | 22 | 19,023,795 | 19,109,967 | RGD:6480464 | CTD | |
| G | DHCR24 | 24-dehydrocholesterol reductase |
|
multiple interactions | ISO | 1 | 55,315,300 | 55,352,921 | RGD:6480464 | CTD | |
| G | DHRS3 | dehydrogenase/reductase (SDR family) member 3 |
|
decreases expression | ISO | 1 | 12,627,939 | 12,677,820 | RGD:6480464 | CTD | |
| G | DLL1 | delta-like 1 (Drosophila) |
|
multiple interactions | ISO | 6 | 170,591,294 | 170,599,697 | RGD:6480464 | CTD | |
| G | DLL1 | delta-like 1 (Drosophila) |
|
increases expression | ISO | 6 | 170,591,294 | 170,599,697 | RGD:6480464 | CTD | |
| G | DMTF1 | cyclin D binding myb-like transcription factor 1 |
|
multiple interactions | ISO | 7 | 86,781,677 | 86,825,648 | RGD:6480464 | CTD | |
| G | DMTF1 | cyclin D binding myb-like transcription factor 1 |
|
increases expression | ISO | 7 | 86,781,677 | 86,825,648 | RGD:6480464 | CTD | |
| G | DNAJA1 | DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
decreases expression | ISO | 9 | 33,025,209 | 33,039,062 | RGD:6480464 | CTD | |
| G | DNAJB9 | DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression | EXP | 7 | 108,210,189 | 108,215,294 | RGD:6480464 | CTD | |
| G | DNAJC2 | DnaJ (Hsp40) homolog, subfamily C, member 2 |
|
increases expression | ISO | 7 | 102,952,921 | 102,985,320 | RGD:6480464 | CTD | |
| G | DNAJC3 | DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
increases expression | ISO | 13 | 96,329,393 | 96,447,243 | RGD:6480464 | CTD | |
| G | DNMT1 | DNA (cytosine-5-)-methyltransferase 1 |
|
increases expression | ISO | 19 | 10,244,022 | 10,305,755 | RGD:6480464 | CTD | |
| G | DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha |
|
decreases expression | ISO | 2 | 25,455,830 | 25,565,459 | RGD:6480464 | CTD | |
| G | DYNLL1 | dynein, light chain, LC8-type 1 |
|
increases expression | ISO | 12 | 120,907,660 | 120,936,298 | RGD:6480464 | CTD | |
| G | DYNLL2 | dynein, light chain, LC8-type 2 |
|
decreases expression | ISO | 17 | 56,160,780 | 56,167,618 | RGD:6480464 | CTD | |
| G | ECE1 | endothelin converting enzyme 1 |
|
multiple interactions | ISO | 1 | 21,543,740 | 21,672,034 | RGD:6480464 | CTD | |
| G | ECH1 | enoyl CoA hydratase 1, peroxisomal |
|
increases expression | ISO | 19 | 39,306,062 | 39,322,497 | RGD:6480464 | CTD | |
| G | ECI1 | enoyl-CoA delta isomerase 1 |
|
increases expression | ISO | 16 | 2,289,873 | 2,301,602 | RGD:6480464 | CTD | |
| G | ECM1 | extracellular matrix protein 1 |
|
multiple interactions | ISO | 1 | 150,480,487 | 150,486,265 | RGD:6480464 | CTD | |
| G | ECM1 | extracellular matrix protein 1 |
|
decreases expression | ISO | 1 | 150,480,487 | 150,486,265 | RGD:6480464 | CTD | |
| G | EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 |
|
multiple interactions | EXP | 6 | 74,225,473 | 74,230,755 | RGD:6480464 | CTD | |
| G | EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 |
|
increases expression | EXP | 20 | 62,119,365 | 62,130,668 | RGD:6480464 | CTD | |
| G | EEF1D | eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
|
increases expression | ISO | 8 | 144,661,867 | 144,679,845 | RGD:6480464 | CTD | |
| G | EEF2 | eukaryotic translation elongation factor 2 |
|
decreases expression | ISO | 19 | 3,976,054 | 3,985,461 | RGD:6480464 | CTD | |
| G | EFNB1 | ephrin-B1 |
|
increases expression | ISO | X | 68,048,840 | 68,062,007 | RGD:6480464 | CTD | |
| G | EGFR | epidermal growth factor receptor |
|
decreases expression | ISO | 7 | 55,086,725 | 55,275,031 | RGD:6480464 | CTD | |
| G | EGFR | epidermal growth factor receptor |
|
decreases expression | ISO | 7 | 55,086,725 | 55,275,031 | RGD:6480464 | CTD | |
| G | EGR1 | early growth response 1 |
|
multiple interactions | ISO | 5 | 137,801,181 | 137,805,004 | RGD:6480464 | CTD | |
| G | EGR3 | early growth response 3 |
|
increases expression | EXP | 8 | 22,545,174 | 22,550,815 | RGD:6480464 | CTD | |
| G | EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
increases expression | ISO | 3 | 184,908,412 | 184,971,886 | RGD:6480464 | CTD | |
| G | EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
increases expression | ISO | 3 | 184,908,412 | 184,971,886 | RGD:6480464 | CTD | |
| G | EI24 | etoposide induced 2.4 |
|
multiple interactions | ISO | 11 | 125,439,298 | 125,454,575 | RGD:6480464 | CTD | |
| G | EID1 | EP300 interacting inhibitor of differentiation 1 |
|
increases expression | ISO | 15 | 49,170,290 | 49,172,380 | RGD:6480464 | CTD | |
| G | EIF2S1 | eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
|
increases expression | ISO | 14 | 67,827,034 | 67,853,233 | RGD:6480464 | CTD | |
| G | EIF3J | eukaryotic translation initiation factor 3, subunit J |
|
decreases expression | ISO | 15 | 44,829,266 | 44,855,001 | RGD:6480464 | CTD | |
| G | EIF5 | eukaryotic translation initiation factor 5 |
|
increases expression | ISO | 14 | 103,800,339 | 103,811,362 | RGD:6480464 | CTD | |
| G | EIF5 | eukaryotic translation initiation factor 5 |
|
increases expression | ISO | 14 | 103,800,339 | 103,811,362 | RGD:6480464 | CTD | |
| G | EIF5A | eukaryotic translation initiation factor 5A |
|
decreases expression | ISO | 17 | 7,210,318 | 7,215,782 | RGD:6480464 | CTD | |
| G | ELOVL3 | ELOVL fatty acid elongase 3 |
|
decreases expression | ISO | 10 | 103,986,143 | 103,989,346 | RGD:6480464 | CTD | |
| G | ELOVL6 | ELOVL fatty acid elongase 6 |
|
increases expression | EXP | 4 | 110,970,229 | 111,119,820 | RGD:6480464 | CTD | |
| G | ELOVL6 | ELOVL fatty acid elongase 6 |
|
increases expression | ISO | 4 | 110,970,229 | 111,119,820 | RGD:6480464 | CTD | |
| G | ENC1 | ectodermal-neural cortex 1 (with BTB domain) |
|
affects expression | ISO | 5 | 73,923,231 | 73,937,249 | RGD:6480464 | CTD | |
| G | ENO1 | enolase 1, (alpha) |
|
increases expression | ISO | 1 | 8,921,059 | 8,939,151 | RGD:6480464 | CTD | |
| G | ENO1 | enolase 1, (alpha) |
|
increases expression | ISO | 1 | 8,921,059 | 8,939,151 | RGD:6480464 | CTD | |
| G | ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
increases expression | ISO | 8 | 120,569,317 | 120,651,106 | RGD:6480464 | CTD | |
| G | EPAS1 | endothelial PAS domain protein 1 |
|
decreases expression | ISO | 2 | 46,524,541 | 46,613,842 | RGD:6480464 | CTD | |
| G | EPAS1 | endothelial PAS domain protein 1 |
|
increases expression | ISO | 2 | 46,524,541 | 46,613,842 | RGD:6480464 | CTD | |
| G | EPHB3 | EPH receptor B3 |
|
decreases expression | ISO | 3 | 184,279,587 | 184,300,196 | RGD:6480464 | CTD | |
| G | EPHX2 | epoxide hydrolase 2, cytoplasmic |
|
increases expression | ISO | 8 | 27,348,519 | 27,402,439 | RGD:6480464 | CTD | |
| G | EPHX2 | epoxide hydrolase 2, cytoplasmic |
|
multiple interactions | ISO | 8 | 27,348,519 | 27,402,439 | RGD:6480464 | CTD | |
| G | ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
decreases expression | ISO | 17 | 37,844,393 | 37,884,915 | RGD:6480464 | CTD | |
| G | ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
multiple interactions | ISO | 12 | 56,473,809 | 56,497,291 | RGD:6480464 | CTD | |
| G | ERGIC3 | ERGIC and golgi 3 |
|
decreases expression | ISO | 20 | 34,129,778 | 34,145,405 | RGD:6480464 | CTD | |
| G | ERMP1 | endoplasmic reticulum metallopeptidase 1 |
|
increases expression | ISO | 9 | 5,784,572 | 5,833,081 | RGD:6480464 | CTD | |
| G | ETF1 | eukaryotic translation termination factor 1 |
|
increases expression | ISO | 5 | 137,841,782 | 137,878,989 | RGD:6480464 | CTD | |
| G | EVI2A | ecotropic viral integration site 2A |
|
increases expression | EXP | 17 | 29,643,428 | 29,648,767 | RGD:6480464 | CTD | |
| G | F2 | coagulation factor II (thrombin) |
|
decreases expression | ISO | 11 | 46,740,743 | 46,761,056 | RGD:6480464 | CTD | |
| G | F2RL3 | coagulation factor II (thrombin) receptor-like 3 |
|
increases expression | ISO | 19 | 16,999,826 | 17,002,830 | RGD:6480464 | CTD | |
| G | F9 | coagulation factor IX |
|
decreases expression | ISO | X | 138,612,895 | 138,645,617 | RGD:6480464 | CTD | |
| G | FABP3 | fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) |
|
affects expression | ISO | 1 | 31,838,100 | 31,845,923 | RGD:6480464 | CTD | |
| G | FADD | Fas (TNFRSF6)-associated via death domain |
|
decreases expression | ISO | 11 | 70,049,269 | 70,053,508 | RGD:6480464 | CTD | |
| G | FAF1 | Fas (TNFRSF6) associated factor 1 |
|
increases expression | ISO | 1 | 50,906,935 | 51,425,936 | RGD:6480464 | CTD | |
| G | FASN | fatty acid synthase |
|
increases expression | ISO | 17 | 80,036,214 | 80,056,106 | RGD:6480464 | CTD | |
| G | FASN | fatty acid synthase |
|
increases expression | ISO | 17 | 80,036,214 | 80,056,106 | RGD:6480464 | CTD | |
| G | FBXO3 | F-box protein 3 |
|
multiple interactions | ISO | 11 | 33,762,490 | 33,796,071 | RGD:6480464 | CTD | |
| G | FBXO33 | F-box protein 33 |
|
affects expression | ISO | 14 | 39,865,577 | 39,901,704 | RGD:6480464 | CTD | |
| G | FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
increases expression | ISO | 1 | 149,754,250 | 149,764,074 | RGD:6480464 | CTD | |
| G | FDFT1 | farnesyl-diphosphate farnesyltransferase 1 |
|
decreases expression | ISO | 8 | 11,660,190 | 11,696,818 | RGD:6480464 | CTD | |
| G | FDPS | farnesyl diphosphate synthase |
|
decreases expression | ISO | 1 | 155,278,539 | 155,290,457 | RGD:6480464 | CTD | |
| G | FDX1 | ferredoxin 1 |
|
increases expression | ISO | 11 | 110,300,661 | 110,335,608 | RGD:6480464 | CTD | |
| G | FGB | fibrinogen beta chain |
|
decreases expression | ISO | 4 | 155,484,132 | 155,493,915 | RGD:6480464 | CTD | |
| G | FGF6 | fibroblast growth factor 6 |
|
increases expression | ISO | 12 | 4,543,308 | 4,554,780 | RGD:6480464 | CTD | |
| G | FGF7 | fibroblast growth factor 7 |
|
increases expression | ISO | 15 | 49,715,375 | 49,779,523 | RGD:6480464 | CTD | |
| G | FILIP1L | filamin A interacting protein 1-like |
|
increases expression | EXP | 3 | 99,551,988 | 99,833,349 | RGD:6480464 | CTD | |
| G | FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) |
|
decreases expression | ISO | 7 | 100,882,893 | 100,888,371 | RGD:6480464 | CTD | |
| G | FKBP1A | FK506 binding protein 1A, 12kDa |
|
decreases expression | ISO | 20 | 1,349,621 | 1,373,816 | RGD:6480464 | CTD | |
| G | FNDC5 | fibronectin type III domain containing 5 |
|
affects expression | ISO | 1 | 33,327,869 | 33,338,082 | RGD:6480464 | CTD | |
| G | FOLR1 | folate receptor 1 (adult) |
|
affects expression | ISO | 11 | 71,900,602 | 71,907,367 | RGD:6480464 | CTD | |
| G | FOXA3 | forkhead box A3 |
|
decreases expression | ISO | 19 | 46,367,518 | 46,377,055 | RGD:6480464 | CTD | |
| G | FXYD1 | FXYD domain containing ion transport regulator 1 |
|
decreases expression | ISO | 19 | 35,629,732 | 35,633,954 | RGD:6480464 | CTD | |
| G | FZD6 | frizzled family receptor 6 |
|
increases expression | ISO | 8 | 104,310,661 | 104,345,094 | RGD:6480464 | CTD | |
| G | G0S2 | G0/G1switch 2 |
|
decreases expression | ISO | 1 | 209,848,670 | 209,849,735 | RGD:6480464 | CTD | |
| G | GABBR1 | gamma-aminobutyric acid (GABA) B receptor, 1 |
|
multiple interactions | EXP | 6 | 29,570,005 | 29,600,962 | RGD:6480464 | CTD | |
| G | GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
multiple interactions | EXP | 5 | 161,274,197 | 161,326,965 | RGD:6480464 | CTD | |
| G | GABRB1 | gamma-aminobutyric acid (GABA) A receptor, beta 1 |
|
multiple interactions | EXP | 4 | 47,033,295 | 47,428,462 | RGD:6480464 | CTD | |
| G | GADD45A | growth arrest and DNA-damage-inducible, alpha |
|
increases expression | EXP | 1 | 68,150,860 | 68,154,021 | RGD:6480464 | CTD | |
| G | GADD45A | growth arrest and DNA-damage-inducible, alpha |
|
increases expression | ISO | 1 | 68,150,860 | 68,154,021 | RGD:6480464 | CTD | |
| G | GALNT1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) |
|
increases expression | ISO | 18 | 33,234,533 | 33,291,798 | RGD:6480464 | CTD | |
| G | GANAB | glucosidase, alpha; neutral AB |
|
decreases expression | ISO | 11 | 62,392,298 | 62,414,104 | RGD:6480464 | CTD | |
| G | GARS | glycyl-tRNA synthetase |
|
increases expression | ISO | 7 | 30,634,181 | 30,673,649 | RGD:6480464 | CTD | |
| G | GATA2 | GATA binding protein 2 |
|
increases expression | ISO | 3 | 128,198,265 | 128,212,030 | RGD:6480464 | CTD | |
| G | GBE1 | glucan (1,4-alpha-), branching enzyme 1 |
|
increases expression | ISO | 3 | 81,538,850 | 81,810,950 | RGD:6480464 | CTD | |
| G | GCLM | glutamate-cysteine ligase, modifier subunit |
|
increases expression | ISO | 1 | 94,352,590 | 94,375,012 | RGD:6480464 | CTD | |
| G | GDA | guanine deaminase |
|
increases expression | ISO | 9 | 74,729,511 | 74,867,140 | RGD:6480464 | CTD | |
| G | GDAP2 | ganglioside induced differentiation associated protein 2 |
|
increases expression | ISO | 1 | 118,406,107 | 118,472,302 | RGD:6480464 | CTD | |
| G | GHR | growth hormone receptor |
|
decreases expression | ISO | 5 | 42,423,877 | 42,721,980 | RGD:6480464 | CTD | |
| G | GHR | growth hormone receptor |
|
decreases expression | ISO | 5 | 42,423,877 | 42,721,980 | RGD:6480464 | CTD | |
| G | GJA3 | gap junction protein, alpha 3, 46kDa |
|
multiple interactions | ISO | 13 | 20,712,394 | 20,735,183 | RGD:6480464 | CTD | |
| G | GK | glycerol kinase |
|
increases expression | ISO | X | 30,671,476 | 30,749,579 | RGD:6480464 | CTD | |
| G | GLO1 | glyoxalase I |
|
decreases expression | ISO | 6 | 38,643,701 | 38,670,952 | RGD:6480464 | CTD | |
| G | GLRA1 | glycine receptor, alpha 1 |
|
increases response to substance | EXP | 5 | 151,202,074 | 151,304,397 | RGD:6480464 | CTD | |
| G | GLRA1 | glycine receptor, alpha 1 |
|
multiple interactions | EXP | 5 | 151,202,074 | 151,304,397 | RGD:6480464 | CTD | |
| G | GLRA1 | glycine receptor, alpha 1 |
|
affects response to substance | EXP | 5 | 151,202,074 | 151,304,397 | RGD:6480464 | CTD | |
| G | GLUL | glutamate-ammonia ligase |
|
decreases expression | ISO | 1 | 182,350,839 | 182,361,341 | RGD:6480464 | CTD | |
| G | GM2A | GM2 ganglioside activator |
|
decreases expression | ISO | 5 | 150,632,613 | 150,649,955 | RGD:6480464 | CTD | |
| G | GMFB | glia maturation factor, beta |
|
affects expression | ISO | 14 | 54,941,209 | 54,955,744 | RGD:6480464 | CTD | |
| G | GMPR | guanosine monophosphate reductase |
|
affects expression | ISO | 6 | 16,238,811 | 16,295,780 | RGD:6480464 | CTD | |
| G | GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
|
increases expression | ISO | 19 | 3,094,408 | 3,121,468 | RGD:6480464 | CTD | |
| G | GNAS | GNAS complex locus |
|
multiple interactions | ISO | 20 | 57,414,795 | 57,486,250 | RGD:6480464 | CTD | |
| G | GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
increases expression | ISO | 1 | 1,716,725 | 1,822,526 | RGD:6480464 | CTD | |
| G | GNE | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
|
decreases expression | ISO | 9 | 36,214,438 | 36,277,053 | RGD:6480464 | CTD | |
| G | GNMT | glycine N-methyltransferase |
|
decreases expression | ISO | 6 | 42,928,500 | 42,931,618 | RGD:6480464 | CTD | |
| G | GNPTG | N-acetylglucosamine-1-phosphate transferase, gamma subunit |
|
increases expression | ISO | 16 | 1,401,900 | 1,413,352 | RGD:6480464 | CTD | |
| G | GP1BB | glycoprotein Ib (platelet), beta polypeptide |
|
decreases expression | ISO | 22 | 19,711,066 | 19,712,297 | RGD:6480464 | CTD | |
| G | GPD2 | glycerol-3-phosphate dehydrogenase 2 (mitochondrial) |
|
increases expression | ISO | 2 | 157,291,965 | 157,442,915 | RGD:6480464 | CTD | |
| G | GPNMB | glycoprotein (transmembrane) nmb |
|
decreases expression | ISO | 7 | 23,286,316 | 23,314,729 | RGD:6480464 | CTD | |
| G | GPR162 | G protein-coupled receptor 162 |
|
affects expression | ISO | 12 | 6,930,963 | 6,936,583 | RGD:6480464 | CTD | |
| G | GRK5 | G protein-coupled receptor kinase 5 |
|
decreases expression | ISO | 10 | 120,967,197 | 121,215,131 | RGD:6480464 | CTD | |
| G | GSPT1 | G1 to S phase transition 1 |
|
increases expression | ISO | 16 | 11,961,985 | 12,010,519 | RGD:6480464 | CTD | |
| G | GSTA3 | glutathione S-transferase alpha 3 |
|
increases expression | ISO | 6 | 52,761,437 | 52,774,496 | RGD:6480464 | CTD | |
| G | GSTA5 | glutathione S-transferase alpha 5 |
|
increases expression | ISO | 6 | 52,696,540 | 52,710,893 | RGD:6480464 | CTD | |
| G | GSTA5 | glutathione S-transferase alpha 5 |
|
increases expression | ISO | 6 | 52,696,540 | 52,710,893 | RGD:6480464 | CTD | |
| G | GSTO1 | glutathione S-transferase omega 1 |
|
increases expression | EXP | 10 | 106,013,952 | 106,027,222 | RGD:6480464 | CTD | |
| G | GSTO1 | glutathione S-transferase omega 1 |
|
multiple interactions | ISO | 10 | 106,013,952 | 106,027,222 | RGD:6480464 | CTD | |
| G | GSTO1 | glutathione S-transferase omega 1 |
|
increases expression | EXP | 10 | 106,013,952 | 106,027,222 | RGD:6480464 | CTD | |
| G | GSTT1 | glutathione S-transferase theta 1 |
|
decreases expression | ISO | 22 | 24,376,139 | 24,384,284 | RGD:6480464 | CTD | |
| G | GTPBP4 | GTP binding protein 4 |
|
decreases expression | ISO | 10 | 1,034,349 | 1,063,708 | RGD:6480464 | CTD | |
| G | H2AFZ | H2A histone family, member Z |
|
decreases expression | ISO | 4 | 100,869,244 | 100,871,512 | RGD:6480464 | CTD | |
| G | HAO2 | hydroxyacid oxidase 2 (long chain) |
|
increases expression | ISO | 1 | 119,911,402 | 119,936,751 | RGD:6480464 | CTD | |
| G | HCCS | holocytochrome c synthase |
|
increases expression | ISO | X | 11,129,406 | 11,141,206 | RGD:6480464 | CTD | |
| G | HERC1 | HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
|
decreases expression | ISO | 15 | 63,900,817 | 64,126,147 | RGD:6480464 | CTD | |
| G | HERC5 | HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
|
increases expression | EXP | 4 | 89,378,268 | 89,427,321 | RGD:6480464 | CTD | |
| G | HIVEP2 | human immunodeficiency virus type I enhancer binding protein 2 |
|
increases expression | EXP | 6 | 143,072,604 | 143,266,338 | RGD:6480464 | CTD | |
| G | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 |
|
multiple interactions | ISO | 1 | 41,972,036 | 42,501,596 | RGD:6480464 | CTD | |
| G | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 |
|
increases expression | ISO | 1 | 41,972,036 | 42,501,596 | RGD:6480464 | CTD | |
| G | HLA-B | major histocompatibility complex, class I, B |
|
increases expression | ISO | 6 | 31,321,649 | 31,324,989 | RGD:6480464 | CTD | |
| G | HLA-DMB | major histocompatibility complex, class II, DM beta |
|
increases expression | ISO | 6 | 32,902,406 | 32,908,847 | RGD:6480464 | CTD | |
| G | HLA-DOA | major histocompatibility complex, class II, DO alpha |
|
increases expression | ISO | 6 | 32,971,959 | 32,977,389 | RGD:6480464 | CTD | |
| G | HLA-DOA | major histocompatibility complex, class II, DO alpha |
|
multiple interactions | ISO | 6 | 32,971,959 | 32,977,389 | RGD:6480464 | CTD | |
| G | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
|
increases expression | ISO | 6 | 32,605,183 | 32,611,429 | RGD:6480464 | CTD | |
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
increases expression | ISO | 6 | 32,546,546 | 32,557,613 | RGD:6480464 | CTD | |
| G | HLA-E | major histocompatibility complex, class I, E |
|
increases expression | ISO | 6 | 30,457,183 | 30,461,982 | RGD:6480464 | CTD | |
| G | HMGN1 | high mobility group nucleosome binding domain 1 |
|
increases expression | ISO | 21 | 40,714,241 | 40,721,047 | RGD:6480464 | CTD | |
| G | HMMR | hyaluronan-mediated motility receptor (RHAMM) |
|
increases expression | EXP | 5 | 162,887,517 | 162,918,951 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HNRNPAB | heterogeneous nuclear ribonucleoprotein A/B |
|
increases expression | ISO | 5 | 177,631,508 | 177,638,184 | RGD:6480464 | CTD | |
| G | HNRNPH1 | heterogeneous nuclear ribonucleoprotein H1 (H) |
|
increases expression | ISO | 5 | 179,041,179 | 179,050,722 | RGD:6480464 | CTD | |
| G | HNRPLL | heterogeneous nuclear ribonucleoprotein L-like |
|
increases expression | EXP | 2 | 38,790,328 | 38,830,178 | RGD:6480464 | CTD | |
| G | HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 |
|
increases expression | ISO | 5 | 118,788,138 | 118,878,030 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
increases expression | ISO | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
multiple interactions | ISO | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
increases expression | ISO | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSPA2 | heat shock 70kDa protein 2 |
|
multiple interactions | ISO | 14 | 65,007,186 | 65,009,955 | RGD:6480464 | CTD | |
| G | HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
decreases expression | ISO | 9 | 127,997,127 | 128,003,666 | RGD:6480464 | CTD | |
| G | HSPA8 | heat shock 70kDa protein 8 |
|
increases expression | ISO | 11 | 122,928,200 | 122,932,901 | RGD:6480464 | CTD | |
| G | HSPA8 | heat shock 70kDa protein 8 |
|
decreases expression | ISO | 11 | 122,928,200 | 122,932,901 | RGD:6480464 | CTD | |
| G | HSPB1 | heat shock 27kDa protein 1 |
|
increases expression | ISO | 7 | 75,931,875 | 75,933,614 | RGD:6480464 | CTD | |
| G | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) |
|
multiple interactions | ISO | 2 | 198,364,721 | 198,368,187 | RGD:6480464 | CTD | |
| G | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) |
|
increases expression | ISO | 2 | 198,364,721 | 198,368,187 | RGD:6480464 | CTD | |
| G | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) |
|
multiple interactions | ISO | 2 | 198,364,721 | 198,368,187 | RGD:6480464 | CTD | |
| G | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) |
|
increases expression | ISO | 2 | 198,364,721 | 198,368,187 | RGD:6480464 | CTD | |
| G | HSPH1 | heat shock 105kDa/110kDa protein 1 |
|
increases expression | ISO | 13 | 31,710,762 | 31,736,117 | RGD:6480464 | CTD | |
| G | HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
multiple interactions | ISO | 11 | 113,845,797 | 113,861,035 | RGD:6480464 | CTD | |
| G | HTRA1 | HtrA serine peptidase 1 |
|
decreases expression | ISO | 10 | 124,221,041 | 124,274,424 | RGD:6480464 | CTD | |
| G | ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
|
multiple interactions | ISO | 2 | 8,822,113 | 8,824,583 | RGD:6480464 | CTD | |
| G | IDE | insulin-degrading enzyme |
|
increases expression | ISO | 10 | 94,211,441 | 94,333,852 | RGD:6480464 | CTD | |
| G | IDE | insulin-degrading enzyme |
|
increases expression | ISO | 10 | 94,211,441 | 94,333,852 | RGD:6480464 | CTD | |
| G | IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression | EXP | 10 | 91,152,303 | 91,166,244 | RGD:6480464 | CTD | |
| G | IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
decreases expression | ISO | 10 | 91,152,303 | 91,166,244 | RGD:6480464 | CTD | |
| G | IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 |
|
increases expression | EXP | 10 | 91,061,706 | 91,069,033 | RGD:6480464 | CTD | |
| G | IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression | EXP | 10 | 91,087,602 | 91,100,725 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
multiple interactions | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
multiple interactions | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
decreases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
decreases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
decreases secretion | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNGR1 | interferon gamma receptor 1 |
|
multiple interactions | ISO | 6 | 137,518,621 | 137,540,567 | RGD:6480464 | CTD | |
| G | IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) |
|
increases expression | EXP | 21 | 34,775,202 | 34,809,828 | RGD:6480464 | CTD | |
| G | IGFBP3 | insulin-like growth factor binding protein 3 |
|
multiple interactions | ISO | 7 | 45,951,844 | 45,960,871 | RGD:6480464 | CTD | |
| G | IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
affects expression | ISO | X | 153,770,459 | 153,793,261 | RGD:6480464 | CTD | |
| G | IL10 | interleukin 10 |
|
decreases expression | ISO | 1 | 206,940,948 | 206,945,839 | RGD:6480464 | CTD | |
| G | IL13RA1 | interleukin 13 receptor, alpha 1 |
|
multiple interactions | ISO | X | 117,861,559 | 117,928,496 | RGD:6480464 | CTD | |
| G | IL13RA1 | interleukin 13 receptor, alpha 1 |
|
multiple interactions | ISO | X | 117,861,559 | 117,928,496 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1R1 | interleukin 1 receptor, type I |
|
decreases expression | ISO | 2 | 102,770,402 | 102,796,334 | RGD:6480464 | CTD | |
| G | IL1RAP | interleukin 1 receptor accessory protein |
|
affects expression | ISO | 3 | 190,231,840 | 190,374,986 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
multiple interactions | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
increases expression | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
decreases secretion | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
decreases expression | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL21 | interleukin 21 |
|
increases secretion | ISO | 4 | 123,533,783 | 123,542,212 | RGD:6480464 | CTD | |
| G | IL2RG | interleukin 2 receptor, gamma |
|
increases expression | ISO | X | 70,327,254 | 70,331,481 | RGD:6480464 | CTD | |
| G | IL3RA | interleukin 3 receptor, alpha (low affinity) |
|
multiple interactions | ISO | X Y |
1,455,509 1,405,509 |
1,501,582 1,451,582 |
RGD:6480464 | CTD | |
| G | IL3RA | interleukin 3 receptor, alpha (low affinity) |
|
increases expression | ISO | X Y |
1,455,509 1,405,509 |
1,501,582 1,451,582 |
RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
increases response to substance | EXP | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
multiple interactions | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
decreases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
increases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
increases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
decreases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
decreases secretion | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL5 | interleukin 5 (colony-stimulating factor, eosinophil) |
|
decreases expression | ISO | 5 | 131,877,136 | 131,879,214 | RGD:6480464 | CTD | |
| G | IL6R | interleukin 6 receptor |
|
increases expression | ISO | 1 | 154,377,669 | 154,441,926 | RGD:6480464 | CTD | |
| G | IL7R | interleukin 7 receptor |
|
decreases expression | ISO | 5 | 35,856,977 | 35,879,705 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL9 | interleukin 9 |
|
increases expression | ISO | 5 | 135,227,935 | 135,231,516 | RGD:6480464 | CTD | |
| G | IMP3 | IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
|
increases expression | ISO | 15 | 75,931,426 | 75,932,664 | RGD:6480464 | CTD | |
| G | INMT | indolethylamine N-methyltransferase |
|
decreases expression | ISO | 7 | 30,791,751 | 30,797,218 | RGD:6480464 | CTD | |
| G | IREB2 | iron-responsive element binding protein 2 |
|
decreases expression | ISO | 15 | 78,730,518 | 78,793,798 | RGD:6480464 | CTD | |
| G | IREB2 | iron-responsive element binding protein 2 |
|
increases expression | ISO | 15 | 78,730,518 | 78,793,798 | RGD:6480464 | CTD | |
| G | ISOC1 | isochorismatase domain containing 1 |
|
increases expression | ISO | 5 | 128,430,442 | 128,449,721 | RGD:6480464 | CTD | |
| G | ITGB7 | integrin, beta 7 |
|
multiple interactions | ISO | 12 | 53,585,107 | 53,601,000 | RGD:6480464 | CTD | |
| G | ITGB7 | integrin, beta 7 |
|
increases expression | ISO | 12 | 53,585,107 | 53,601,000 | RGD:6480464 | CTD | |
| G | ITIH2 | inter-alpha-trypsin inhibitor heavy chain 2 |
|
multiple interactions | ISO | 10 | 7,745,236 | 7,791,483 | RGD:6480464 | CTD | |
| G | IVD | isovaleryl-CoA dehydrogenase |
|
decreases expression | ISO | 15 | 40,697,686 | 40,713,512 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
multiple interactions | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
decreases methylation | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
multiple interactions | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
increases expression | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
multiple interactions | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
multiple interactions | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
decreases methylation | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
multiple interactions | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
multiple interactions | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUND | jun D proto-oncogene |
|
increases expression | ISO | 19 | 18,390,563 | 18,392,432 | RGD:6480464 | CTD | |
| G | JUND | jun D proto-oncogene |
|
multiple interactions | ISO | 19 | 18,390,563 | 18,392,432 | RGD:6480464 | CTD | |
| G | JUP | junction plakoglobin |
|
decreases expression | ISO | 17 | 39,910,859 | 39,942,964 | RGD:6480464 | CTD | |
| G | KCTD1 | potassium channel tetramerisation domain containing 1 |
|
affects expression | ISO | 18 | 24,034,874 | 24,237,365 | RGD:6480464 | CTD | |
| G | KDELR2 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
decreases expression | ISO | 7 | 6,500,712 | 6,523,849 | RGD:6480464 | CTD | |
| G | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
multiple interactions | ISO | 4 | 55,944,426 | 55,991,762 | RGD:6480464 | CTD | |
| G | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
increases expression | ISO | 4 | 55,944,426 | 55,991,762 | RGD:6480464 | CTD | |
| G | KIFC2 | kinesin family member C2 |
|
decreases expression | ISO | 8 | 145,691,738 | 145,699,499 | RGD:6480464 | CTD | |
| G | KLF3 | Kruppel-like factor 3 (basic) |
|
increases expression | ISO | 4 | 38,665,790 | 38,703,129 | RGD:6480464 | CTD | |
| G | KLHL9 | kelch-like family member 9 |
|
decreases expression | ISO | 9 | 21,331,018 | 21,335,429 | RGD:6480464 | CTD | |
| G | LACTB2 | lactamase, beta 2 |
|
decreases expression | ISO | 8 | 71,549,501 | 71,581,447 | RGD:6480464 | CTD | |
| G | LAMB3 | laminin, beta 3 |
|
increases expression | ISO | 1 | 209,788,215 | 209,825,820 | RGD:6480464 | CTD | |
| G | LAMC1 | laminin, gamma 1 (formerly LAMB2) |
|
increases expression | ISO | 1 | 182,992,595 | 183,114,727 | RGD:6480464 | CTD | |
| G | LAMTOR2 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 |
|
decreases expression | ISO | 1 | 156,024,517 | 156,028,301 | RGD:6480464 | CTD | |
| G | LAP3 | leucine aminopeptidase 3 |
|
decreases expression | ISO | 4 | 17,578,927 | 17,609,590 | RGD:6480464 | CTD | |
| G | LARP4B | La ribonucleoprotein domain family, member 4B |
|
increases expression | ISO | 10 | 855,484 | 931,702 | RGD:6480464 | CTD | |
| G | LCK | lymphocyte-specific protein tyrosine kinase |
|
increases phosphorylation | ISO | 1 | 32,716,840 | 32,751,766 | RGD:6480464 | CTD | |
| G | LGALS9 | lectin, galactoside-binding, soluble, 9 |
|
decreases expression | ISO | 17 | 25,958,174 | 25,976,586 | RGD:6480464 | CTD | |
| G | LIFR | leukemia inhibitory factor receptor alpha |
|
decreases expression | ISO | 5 | 38,475,065 | 38,595,507 | RGD:6480464 | CTD | |
| G | LIFR | leukemia inhibitory factor receptor alpha |
|
decreases expression | ISO | 5 | 38,475,065 | 38,595,507 | RGD:6480464 | CTD | |
| G | LIMK1 | LIM domain kinase 1 |
|
multiple interactions | ISO | 7 | 73,498,107 | 73,536,855 | RGD:6480464 | CTD | |
| G | LPCAT3 | lysophosphatidylcholine acyltransferase 3 |
|
increases expression | ISO | 12 | 7,085,347 | 7,125,842 | RGD:6480464 | CTD | |
| G | LRP1 | low density lipoprotein receptor-related protein 1 |
|
increases expression | ISO | 12 | 57,522,282 | 57,607,142 | RGD:6480464 | CTD | |
| G | LRRC59 | leucine rich repeat containing 59 |
|
increases expression | ISO | 17 | 48,458,594 | 48,474,914 | RGD:6480464 | CTD | |
| G | LSR | lipolysis stimulated lipoprotein receptor |
|
increases expression | ISO | 19 | 35,739,559 | 35,758,867 | RGD:6480464 | CTD | |
| G | LTA | lymphotoxin alpha (TNF superfamily, member 1) |
|
decreases expression | ISO | 6 | 31,539,876 | 31,542,101 | RGD:6480464 | CTD | |
| G | LTBR | lymphotoxin beta receptor (TNFR superfamily, member 3) |
|
multiple interactions | ISO | 12 | 6,484,534 | 6,500,737 | RGD:6480464 | CTD | |
| G | MAB21L2 | mab-21-like 2 (C. elegans) |
|
affects expression | ISO | 4 | 151,503,077 | 151,505,845 | RGD:6480464 | CTD | |
| G | MACF1 | microtubule-actin crosslinking factor 1 |
|
decreases expression | ISO | 1 | 39,547,089 | 39,952,810 | RGD:6480464 | CTD | |
| G | MAG | myelin associated glycoprotein |
|
affects expression | ISO | 19 | 35,782,989 | 35,804,710 | RGD:6480464 | CTD | |
| G | MAP2K2 | mitogen-activated protein kinase kinase 2 |
|
increases expression | ISO | 19 | 4,090,319 | 4,124,126 | RGD:6480464 | CTD | |
| G | MAP3K3 | mitogen-activated protein kinase kinase kinase 3 |
|
multiple interactions | ISO | 17 | 61,699,801 | 61,773,670 | RGD:6480464 | CTD | |
| G | MAP3K4 | mitogen-activated protein kinase kinase kinase 4 |
|
multiple interactions | ISO | 6 | 161,412,822 | 161,538,417 | RGD:6480464 | CTD | |
| G | MAP3K8 | mitogen-activated protein kinase kinase kinase 8 |
|
increases expression | EXP | 10 | 30,722,950 | 30,750,762 | RGD:6480464 | CTD | |
| G | MAP4 | microtubule-associated protein 4 |
|
decreases expression | ISO | 3 | 47,892,180 | 48,130,769 | RGD:6480464 | CTD | |
| G | MAPK14 | mitogen-activated protein kinase 14 |
|
decreases expression | ISO | 6 | 35,995,454 | 36,079,013 | RGD:6480464 | CTD | |
| G | MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 |
|
affects expression | ISO | 11 | 45,907,047 | 45,928,016 | RGD:6480464 | CTD | |
| G | MAPK9 | mitogen-activated protein kinase 9 |
|
increases expression | ISO | 5 | 179,660,594 | 179,719,071 | RGD:6480464 | CTD | |
| G | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 |
|
multiple interactions | ISO | 1 | 206,858,365 | 206,907,630 | RGD:6480464 | CTD | |
| G | MARC2 | mitochondrial amidoxime reducing component 2 |
|
increases expression | ISO | 1 | 220,921,676 | 220,957,599 | RGD:6480464 | CTD | |
| G | MARK2 | MAP/microtubule affinity-regulating kinase 2 |
|
increases expression | ISO | 11 | 63,606,400 | 63,678,492 | RGD:6480464 | CTD | |
| G | MDK | midkine (neurite growth-promoting factor 2) |
|
increases expression | ISO | 11 | 46,402,334 | 46,405,387 | RGD:6480464 | CTD | |
| G | MDM2 | MDM2 oncogene, E3 ubiquitin protein ligase |
|
affects expression | ISO | 12 | 69,201,971 | 69,239,320 | RGD:6480464 | CTD | |
| G | MDM2 | MDM2 oncogene, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 12 | 69,201,971 | 69,239,320 | RGD:6480464 | CTD | |
| G | ME1 | malic enzyme 1, NADP(+)-dependent, cytosolic |
|
increases expression | ISO | 6 | 83,920,108 | 84,140,938 | RGD:6480464 | CTD | |
| G | MEPCE | methylphosphate capping enzyme |
|
affects expression | ISO | 7 | 100,026,413 | 100,031,749 | RGD:6480464 | CTD | |
| G | MET | met proto-oncogene (hepatocyte growth factor receptor) |
|
multiple interactions | ISO | 7 | 116,312,459 | 116,438,440 | RGD:6480464 | CTD | |
| G | MET | met proto-oncogene (hepatocyte growth factor receptor) |
|
increases expression | ISO | 7 | 116,312,459 | 116,438,440 | RGD:6480464 | CTD | |
| G | MFGE8 | milk fat globule-EGF factor 8 protein |
|
decreases expression | ISO | 15 | 89,441,914 | 89,456,663 | RGD:6480464 | CTD | |
| G | MFGE8 | milk fat globule-EGF factor 8 protein |
|
multiple interactions | ISO | 15 | 89,441,914 | 89,456,663 | RGD:6480464 | CTD | |
| G | MFN2 | mitofusin 2 |
|
decreases expression | ISO | 1 | 12,040,238 | 12,073,572 | RGD:6480464 | CTD | |
| G | MGLL | monoglyceride lipase |
|
increases expression | ISO | 3 | 127,407,905 | 127,542,093 | RGD:6480464 | CTD | |
| G | MLC1 | megalencephalic leukoencephalopathy with subcortical cysts 1 |
|
affects expression | ISO | 22 | 50,497,820 | 50,524,358 | RGD:6480464 | CTD | |
| G | MORF4L2 | mortality factor 4 like 2 |
|
increases expression | ISO | X | 102,930,426 | 102,943,086 | RGD:6480464 | CTD | |
| G | MPP3 | membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) |
|
multiple interactions | ISO | 17 | 41,878,167 | 41,910,547 | RGD:6480464 | CTD | |
| G | MRPL50 | mitochondrial ribosomal protein L50 |
|
decreases expression | ISO | 9 | 104,152,249 | 104,160,919 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
decreases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MTDH | metadherin |
|
affects expression | ISO | 8 | 98,656,407 | 98,742,488 | RGD:6480464 | CTD | |
| G | MTDH | metadherin |
|
increases expression | ISO | 8 | 98,656,407 | 98,742,488 | RGD:6480464 | CTD | |
| G | MTERFD1 | MTERF domain containing 1 |
|
decreases expression | ISO | 8 | 97,251,645 | 97,273,796 | RGD:6480464 | CTD | |
| G | MTOR | mechanistic target of rapamycin (serine/threonine kinase) |
|
increases expression | ISO | 1 | 11,166,588 | 11,322,608 | RGD:6480464 | CTD | |
| G | MTPN | myotrophin |
|
multiple interactions | ISO | 7 | 135,611,503 | 135,662,204 | RGD:6480464 | CTD | |
| G | MTPN | myotrophin |
|
increases expression | ISO | 7 | 135,611,503 | 135,662,204 | RGD:6480464 | CTD | |
| G | MXD1 | MAX dimerization protein 1 |
|
increases expression | EXP | 2 | 70,142,173 | 70,170,077 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
decreases methylation | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
affects expression | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
decreases methylation | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
decreases expression | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | NAT1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
increases response to substance | EXP | 8 | 18,027,971 | 18,081,198 | RGD:6480464 | CTD | |
| G | NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases response to substance | EXP | 8 | 18,248,755 | 18,258,723 | RGD:6480464 | CTD | |
| G | NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
decreases expression | ISO | 8 | 18,248,755 | 18,258,723 | RGD:6480464 | CTD | |
| G | NBL1 | neuroblastoma 1, DAN family BMP antagonist |
|
increases expression | ISO | 1 | 19,969,723 | 19,984,949 | RGD:6480464 | CTD | |
| G | NCAM1 | neural cell adhesion molecule 1 |
|
decreases expression | ISO | 11 | 112,831,969 | 113,149,158 | RGD:6480464 | CTD | |
| G | NCF1 | neutrophil cytosolic factor 1 |
|
decreases expression | ISO | 7 | 74,188,309 | 74,203,659 | RGD:6480464 | CTD | |
| G | NCF2 | neutrophil cytosolic factor 2 |
|
increases expression | EXP | 1 | 183,524,697 | 183,560,056 | RGD:6480464 | CTD | |
| G | NCKAP1 | NCK-associated protein 1 |
|
increases expression | ISO | 2 | 183,789,605 | 183,903,229 | RGD:6480464 | CTD | |
| G | NCOR1 | nuclear receptor corepressor 1 |
|
increases expression | ISO | 17 | 15,933,408 | 16,118,874 | RGD:6480464 | CTD | |
| G | NDUFS1 | NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) |
|
multiple interactions | ISO | 2 | 206,987,803 | 207,024,243 | RGD:6480464 | CTD | |
| G | NDUFS8 | NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) |
|
affects expression | ISO | 11 | 67,798,084 | 67,804,114 | RGD:6480464 | CTD | |
| G | NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 |
|
increases expression | EXP | 6 | 11,183,531 | 11,382,581 | RGD:6480464 | CTD | |
| G | NELFE | negative elongation factor complex member E |
|
increases expression | ISO | 6 | 31,919,864 | 31,926,864 | RGD:6480464 | CTD | |
| G | NENF | neudesin neurotrophic factor |
|
decreases expression | ISO | 1 | 212,606,229 | 212,619,721 | RGD:6480464 | CTD | |
| G | NFAT5 | nuclear factor of activated T-cells 5, tonicity-responsive |
|
increases expression | EXP | 16 | 69,599,869 | 69,738,569 | RGD:6480464 | CTD | |
| G | NFATC3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
decreases expression | ISO | 16 | 68,119,269 | 68,263,162 | RGD:6480464 | CTD | |
| G | NFIB | nuclear factor I/B |
|
increases expression | ISO | 9 | 14,081,842 | 14,398,982 | RGD:6480464 | CTD | |
| G | NFIB | nuclear factor I/B |
|
increases expression | EXP | 9 | 14,081,842 | 14,398,982 | RGD:6480464 | CTD | |
| G | NFIB | nuclear factor I/B |
|
increases expression | ISO | 9 | 14,081,842 | 14,398,982 | RGD:6480464 | CTD | |
| G | NFIB | nuclear factor I/B |
|
increases expression | ISO | 9 | 14,081,842 | 14,398,982 | RGD:6480464 | CTD | |
| G | NFIX | nuclear factor I/X (CCAAT-binding transcription factor) |
|
increases expression | ISO | 19 | 13,106,584 | 13,209,610 | RGD:6480464 | CTD | |
| G | NFIX | nuclear factor I/X (CCAAT-binding transcription factor) |
|
increases expression | ISO | 19 | 13,106,584 | 13,209,610 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions | ISO | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression | ISO | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions | ISO | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression | ISO | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression | ISO | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
|
increases expression | ISO | 10 | 104,153,867 | 104,162,286 | RGD:6480464 | CTD | |
| G | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
|
increases expression | ISO | 10 | 104,153,867 | 104,162,286 | RGD:6480464 | CTD | |
| G | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
|
increases expression | ISO | 10 | 104,153,867 | 104,162,286 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression | EXP | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
increases expression | ISO | 19 | 39,390,340 | 39,399,534 | RGD:6480464 | CTD | |
| G | NGF | nerve growth factor (beta polypeptide) |
|
decreases expression | ISO | 1 | 115,828,537 | 115,880,857 | RGD:6480464 | CTD | |
| G | NLN | neurolysin (metallopeptidase M3 family) |
|
affects expression | ISO | 5 | 65,018,023 | 65,125,111 | RGD:6480464 | CTD | |
| G | NOP56 | NOP56 ribonucleoprotein |
|
increases expression | ISO | 20 | 2,633,178 | 2,639,039 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
increases activity | EXP | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | EXP | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
increases expression | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
increases expression | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
increases expression | EXP | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
increases expression | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS3 | nitric oxide synthase 3 (endothelial cell) |
|
increases activity | EXP | 7 | 150,688,144 | 150,711,687 | RGD:6480464 | CTD | |
| G | NOS3 | nitric oxide synthase 3 (endothelial cell) |
|
increases expression | EXP | 7 | 150,688,144 | 150,711,687 | RGD:6480464 | CTD | |
| G | NOS3 | nitric oxide synthase 3 (endothelial cell) |
|
multiple interactions | EXP | 7 | 150,688,144 | 150,711,687 | RGD:6480464 | CTD | |
| G | NR1D2 | nuclear receptor subfamily 1, group D, member 2 |
|
increases expression | ISO | 3 | 23,986,751 | 24,022,109 | RGD:6480464 | CTD | |
| G | NR2F2 | nuclear receptor subfamily 2, group F, member 2 |
|
decreases expression | ISO | 15 | 96,869,157 | 96,883,492 | RGD:6480464 | CTD | |
| G | NR2F6 | nuclear receptor subfamily 2, group F, member 6 |
|
multiple interactions | ISO | 19 | 17,342,694 | 17,356,151 | RGD:6480464 | CTD | |
| G | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
decreases expression | ISO | 5 | 142,657,496 | 142,815,077 | RGD:6480464 | CTD | |
| G | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
decreases expression | ISO | 5 | 142,657,496 | 142,815,077 | RGD:6480464 | CTD | |
| G | NR5A2 | nuclear receptor subfamily 5, group A, member 2 |
|
multiple interactions | ISO | 1 | 199,996,770 | 200,146,552 | RGD:6480464 | CTD | |
| G | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog |
|
increases expression | ISO | 1 | 115,247,085 | 115,259,515 | RGD:6480464 | CTD | |
| G | NTF3 | neurotrophin 3 |
|
decreases expression | ISO | 12 | 5,541,280 | 5,604,465 | RGD:6480464 | CTD | |
| G | NUCB1 | nucleobindin 1 |
|
decreases expression | ISO | 19 | 49,403,307 | 49,426,540 | RGD:6480464 | CTD | |
| G | NUPR1 | nuclear protein, transcriptional regulator, 1 |
|
increases expression | ISO | 16 | 28,548,662 | 28,550,495 | RGD:6480464 | CTD | |
| G | OAT | ornithine aminotransferase |
|
decreases expression | ISO | 10 | 126,085,872 | 126,107,545 | RGD:6480464 | CTD | |
| G | OAZ2 | ornithine decarboxylase antizyme 2 |
|
affects expression | ISO | 15 | 64,979,773 | 64,995,462 | RGD:6480464 | CTD | |
| G | ODC1 | ornithine decarboxylase 1 |
|
increases expression | ISO | 2 | 10,580,508 | 10,588,453 | RGD:6480464 | CTD | |
| G | OSGEP | O-sialoglycoprotein endopeptidase |
|
affects expression | ISO | 14 | 20,915,207 | 20,923,267 | RGD:6480464 | CTD | |
| G | OXCT1 | 3-oxoacid CoA transferase 1 |
|
affects expression | ISO | 5 | 41,730,167 | 41,870,791 | RGD:6480464 | CTD | |
| G | OXR1 | oxidation resistance 1 |
|
increases expression | ISO | 8 | 107,282,406 | 107,764,922 | RGD:6480464 | CTD | |
| G | P2RX3 | purinergic receptor P2X, ligand-gated ion channel, 3 |
|
multiple interactions | EXP | 11 | 57,105,841 | 57,137,549 | RGD:6480464 | CTD | |
| G | P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions | EXP | 3 | 152,552,736 | 152,555,845 | RGD:6480464 | CTD | |
| G | P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 |
|
decreases activity | EXP | 3 | 152,552,736 | 152,555,845 | RGD:6480464 | CTD | |
| G | P2RY4 | pyrimidinergic receptor P2Y, G-protein coupled, 4 |
|
multiple interactions | EXP | X | 69,478,016 | 69,479,654 | RGD:6480464 | CTD | |
| G | P2RY4 | pyrimidinergic receptor P2Y, G-protein coupled, 4 |
|
decreases activity | EXP | X | 69,478,016 | 69,479,654 | RGD:6480464 | CTD | |
| G | PABPC4 | poly(A) binding protein, cytoplasmic 4 (inducible form) |
|
increases expression | ISO | 1 | 40,026,485 | 40,042,521 | RGD:6480464 | CTD | |
| G | PAH | phenylalanine hydroxylase |
|
increases expression | ISO | 12 | 103,232,104 | 103,311,381 | RGD:6480464 | CTD | |
| G | PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
|
increases expression | ISO | 10 | 89,419,476 | 89,507,462 | RGD:6480464 | CTD | |
| G | PATZ1 | POZ (BTB) and AT hook containing zinc finger 1 |
|
increases expression | ISO | 22 | 31,721,790 | 31,742,249 | RGD:6480464 | CTD | |
| G | PCCB | propionyl CoA carboxylase, beta polypeptide |
|
decreases expression | ISO | 3 | 135,969,167 | 136,049,013 | RGD:6480464 | CTD | |
| G | PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) |
|
decreases expression | ISO | 20 | 56,136,137 | 56,141,513 | RGD:6480464 | CTD | |
| G | PCNA | proliferating cell nuclear antigen |
|
increases expression | ISO | 20 | 5,095,599 | 5,107,268 | RGD:6480464 | CTD | |
| G | PDCD6IP | programmed cell death 6 interacting protein |
|
decreases expression | ISO | 3 | 33,840,063 | 33,911,199 | RGD:6480464 | CTD | |
| G | PDCL | phosducin-like |
|
increases expression | ISO | 9 | 125,580,376 | 125,590,935 | RGD:6480464 | CTD | |
| G | PDCL3 | phosducin-like 3 |
|
multiple interactions | ISO | 2 | 101,179,418 | 101,193,201 | RGD:6480464 | CTD | |
| G | PDE3B | phosphodiesterase 3B, cGMP-inhibited |
|
increases expression | ISO | 11 | 14,665,269 | 14,893,605 | RGD:6480464 | CTD | |
| G | PDGFB | platelet-derived growth factor beta polypeptide |
|
multiple interactions | ISO | 22 | 39,619,685 | 39,640,957 | RGD:6480464 | CTD | |
| G | PDGFB | platelet-derived growth factor beta polypeptide |
|
increases expression | ISO | 22 | 39,619,685 | 39,640,957 | RGD:6480464 | CTD | |
| G | PDIA3 | protein disulfide isomerase family A, member 3 |
|
decreases expression | ISO | 15 | 44,038,590 | 44,064,804 | RGD:6480464 | CTD | |
| G | PDIA6 | protein disulfide isomerase family A, member 6 |
|
decreases expression | ISO | 2 | 10,923,517 | 10,952,960 | RGD:6480464 | CTD | |
| G | PELI1 | pellino E3 ubiquitin protein ligase 1 |
|
increases expression | EXP | 2 | 64,319,786 | 64,371,605 | RGD:6480464 | CTD | |
| G | PEMT | phosphatidylethanolamine N-methyltransferase |
|
decreases expression | ISO | 17 | 17,408,877 | 17,495,017 | RGD:6480464 | CTD | |
| G | PEMT | phosphatidylethanolamine N-methyltransferase |
|
decreases expression | ISO | 17 | 17,408,877 | 17,495,017 | RGD:6480464 | CTD | |
| G | PEX11A | peroxisomal biogenesis factor 11 alpha |
|
increases expression | ISO | 15 | 90,226,284 | 90,233,958 | RGD:6480464 | CTD | |
| G | PEX11A | peroxisomal biogenesis factor 11 alpha |
|
increases expression | ISO | 15 | 90,226,284 | 90,233,958 | RGD:6480464 | CTD | |
| G | PF4 | platelet factor 4 |
|
decreases expression | ISO | 4 | 74,846,542 | 74,847,841 | RGD:6480464 | CTD | |
| G | PFDN2 | prefoldin subunit 2 |
|
decreases expression | ISO | 1 | 161,070,346 | 161,087,866 | RGD:6480464 | CTD | |
| G | PGAM1 | phosphoglycerate mutase 1 (brain) |
|
increases expression | ISO | 10 | 99,186,027 | 99,193,198 | RGD:6480464 | CTD | |
| G | PGLS | 6-phosphogluconolactonase |
|
increases expression | ISO | 19 | 17,622,432 | 17,632,097 | RGD:6480464 | CTD | |
| G | PHF19 | PHD finger protein 19 |
|
affects expression | ISO | 9 | 123,617,931 | 123,639,606 | RGD:6480464 | CTD | |
| G | PKM | pyruvate kinase, muscle |
|
affects expression | ISO | 15 | 72,491,370 | 72,523,727 | RGD:6480464 | CTD | |
| G | PKP2 | plakophilin 2 |
|
increases expression | ISO | 12 | 32,943,680 | 33,049,780 | RGD:6480464 | CTD | |
| G | PLA2G12A | phospholipase A2, group XIIA |
|
increases expression | ISO | 4 | 110,631,145 | 110,651,242 | RGD:6480464 | CTD | |
| G | PLAA | phospholipase A2-activating protein |
|
increases expression | ISO | 9 | 26,903,368 | 26,947,468 | RGD:6480464 | CTD | |
| G | PLD1 | phospholipase D1, phosphatidylcholine-specific |
|
multiple interactions | ISO | 3 | 171,318,195 | 171,528,284 | RGD:6480464 | CTD | |
| G | PLS3 | plastin 3 |
|
multiple interactions | ISO | X | 114,795,177 | 114,885,181 | RGD:6480464 | CTD | |
| G | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression | EXP | 18 | 57,567,192 | 57,571,538 | RGD:6480464 | CTD | |
| G | PMPCA | peptidase (mitochondrial processing) alpha |
|
decreases expression | ISO | 9 | 139,305,116 | 139,318,213 | RGD:6480464 | CTD | |
| G | POR | P450 (cytochrome) oxidoreductase |
|
multiple interactions | ISO | 7 | 75,544,420 | 75,616,173 | RGD:6480464 | CTD | |
| G | PPA1 | pyrophosphatase (inorganic) 1 |
|
increases expression | ISO | 10 | 71,962,586 | 71,993,190 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases activity | EXP | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases response to substance | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases activity | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
decreases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases response to substance | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARG | peroxisome proliferator-activated receptor gamma |
|
multiple interactions | ISO | 3 | 12,329,349 | 12,475,855 | RGD:6480464 | CTD | |
| G | PPARG | peroxisome proliferator-activated receptor gamma |
|
increases expression | ISO | 3 | 12,329,349 | 12,475,855 | RGD:6480464 | CTD | |
| G | PPM1A | protein phosphatase, Mg2+/Mn2+ dependent, 1A |
|
increases expression | ISO | 14 | 60,712,470 | 60,765,805 | RGD:6480464 | CTD | |
| G | PPM1A | protein phosphatase, Mg2+/Mn2+ dependent, 1A |
|
multiple interactions | ISO | 14 | 60,712,470 | 60,765,805 | RGD:6480464 | CTD | |
| G | PPM1G | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
|
decreases expression | ISO | 2 | 27,604,066 | 27,632,550 | RGD:6480464 | CTD | |
| G | PPP1CB | protein phosphatase 1, catalytic subunit, beta isozyme |
|
increases expression | ISO | 2 | 28,974,614 | 29,025,806 | RGD:6480464 | CTD | |
| G | PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme |
|
multiple interactions | ISO | 12 | 111,157,613 | 111,180,783 | RGD:6480464 | CTD | |
| G | PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme |
|
increases expression | ISO | 5 | 133,532,148 | 133,561,950 | RGD:6480464 | CTD | |
| G | PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme |
|
increases expression | ISO | 8 | 30,643,126 | 30,670,352 | RGD:6480464 | CTD | |
| G | PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme |
|
multiple interactions | ISO | 4 | 101,944,587 | 102,268,628 | RGD:6480464 | CTD | |
| G | PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme |
|
increases expression | ISO | 4 | 101,944,587 | 102,268,628 | RGD:6480464 | CTD | |
| G | PPTC7 | PTC7 protein phosphatase homolog (S. cerevisiae) |
|
increases expression | ISO | 12 | 110,972,237 | 111,021,064 | RGD:6480464 | CTD | |
| G | PRDX1 | peroxiredoxin 1 |
|
increases expression | ISO | 1 | 45,976,707 | 45,988,562 | RGD:6480464 | CTD | |
| G | PRDX1 | peroxiredoxin 1 |
|
increases expression | ISO | 1 | 45,976,707 | 45,988,562 | RGD:6480464 | CTD | |
| G | PRKACA | protein kinase, cAMP-dependent, catalytic, alpha |
|
decreases expression | ISO | 19 | 14,202,500 | 14,228,559 | RGD:6480464 | CTD | |
| G | PRKCD | protein kinase C, delta |
|
decreases expression | ISO | 3 | 53,195,223 | 53,226,733 | RGD:6480464 | CTD | |
| G | PRLR | prolactin receptor |
|
multiple interactions | ISO | 5 | 35,048,861 | 35,230,823 | RGD:6480464 | CTD | |
| G | PRNP | prion protein |
|
decreases expression | ISO | 20 | 4,666,797 | 4,682,234 | RGD:6480464 | CTD | |
| G | PRNP | prion protein |
|
increases expression | EXP | 20 | 4,666,797 | 4,682,234 | RGD:6480464 | CTD | |
| G | PROC | protein C (inactivator of coagulation factors Va and VIIIa) |
|
multiple interactions | ISO | 2 | 128,175,996 | 128,186,822 | RGD:6480464 | CTD | |
| G | PRTN3 | proteinase 3 |
|
multiple interactions | ISO | 19 | 840,985 | 848,175 | RGD:6480464 | CTD | |
| G | PRTN3 | proteinase 3 |
|
increases expression | ISO | 19 | 840,985 | 848,175 | RGD:6480464 | CTD | |
| G | PSMA1 | proteasome (prosome, macropain) subunit, alpha type, 1 |
|
increases expression | ISO | 11 | 14,526,422 | 14,665,180 | RGD:6480464 | CTD | |
| G | PSMA2 | proteasome (prosome, macropain) subunit, alpha type, 2 |
|
increases expression | ISO | 7 | 42,956,460 | 42,971,805 | RGD:6480464 | CTD | |
| G | PSMB2 | proteasome (prosome, macropain) subunit, beta type, 2 |
|
affects expression | ISO | 1 | 36,065,142 | 36,107,445 | RGD:6480464 | CTD | |
| G | PSMB5 | proteasome (prosome, macropain) subunit, beta type, 5 |
|
increases expression | ISO | 14 | 23,495,060 | 23,504,429 | RGD:6480464 | CTD | |
| G | PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 |
|
decreases expression | ISO | 6 | 32,821,938 | 32,827,628 | RGD:6480464 | CTD | |
| G | PSMC6 | proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
affects expression | ISO | 14 | 53,173,896 | 53,194,716 | RGD:6480464 | CTD | |
| G | PSMD1 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
increases expression | ISO | 2 | 231,921,578 | 232,037,541 | RGD:6480464 | CTD | |
| G | PSMD14 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
affects expression | ISO | 2 | 162,164,786 | 162,268,228 | RGD:6480464 | CTD | |
| G | PSMD2 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 |
|
affects expression | ISO | 3 | 184,017,022 | 184,026,840 | RGD:6480464 | CTD | |
| G | PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
affects expression | ISO | 1 | 151,227,197 | 151,239,955 | RGD:6480464 | CTD | |
| G | PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
decreases expression | ISO | 1 | 151,227,197 | 151,239,955 | RGD:6480464 | CTD | |
| G | PSMD5 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 |
|
increases expression | ISO | 9 | 123,578,331 | 123,605,299 | RGD:6480464 | CTD | |
| G | PSMD6 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
affects expression | ISO | 3 | 63,996,231 | 64,009,120 | RGD:6480464 | CTD | |
| G | PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
|
increases expression | ISO | 19 | 38,865,190 | 38,874,464 | RGD:6480464 | CTD | |
| G | PSME4 | proteasome (prosome, macropain) activator subunit 4 |
|
increases expression | ISO | 2 | 54,091,204 | 54,197,977 | RGD:6480464 | CTD | |
| G | PTEN | phosphatase and tensin homolog |
|
multiple interactions | ISO | 10 | 89,623,195 | 89,728,532 | RGD:6480464 | CTD | |
| G | PTEN | phosphatase and tensin homolog |
|
increases expression | ISO | 10 | 89,623,195 | 89,728,532 | RGD:6480464 | CTD | |
| G | PTGDS | prostaglandin D2 synthase 21kDa (brain) |
|
decreases expression | ISO | 9 | 139,871,956 | 139,876,194 | RGD:6480464 | CTD | |
| G | PTGER2 | prostaglandin E receptor 2 (subtype EP2), 53kDa |
|
increases expression | EXP | 14 | 52,781,016 | 52,795,324 | RGD:6480464 | CTD | |
| G | PTGES3 | prostaglandin E synthase 3 (cytosolic) |
|
decreases expression | ISO | 12 | 57,057,125 | 57,082,078 | RGD:6480464 | CTD | |
| G | PTH1R | parathyroid hormone 1 receptor |
|
multiple interactions | ISO | 3 | 46,919,236 | 46,945,289 | RGD:6480464 | CTD | |
| G | PTMS | parathymosin |
|
multiple interactions | ISO | 12 | 6,875,541 | 6,880,118 | RGD:6480464 | CTD | |
| G | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 |
|
increases expression | ISO | 6 | 64,281,920 | 64,293,489 | RGD:6480464 | CTD | |
| G | PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
|
multiple interactions | ISO | 1 | 114,356,433 | 114,414,375 | RGD:6480464 | CTD | |
| G | PTPRA | protein tyrosine phosphatase, receptor type, A |
|
multiple interactions | ISO | 20 | 2,844,841 | 3,019,315 | RGD:6480464 | CTD | |
| G | PTPRF | protein tyrosine phosphatase, receptor type, F |
|
multiple interactions | ISO | 1 | 43,996,547 | 44,089,343 | RGD:6480464 | CTD | |
| G | PTPRN | protein tyrosine phosphatase, receptor type, N |
|
decreases expression | ISO | 2 | 220,154,345 | 220,174,295 | RGD:6480464 | CTD | |
| G | PTPRS | protein tyrosine phosphatase, receptor type, S |
|
decreases expression | ISO | 19 | 5,205,519 | 5,340,814 | RGD:6480464 | CTD | |
| G | PURA | purine-rich element binding protein A |
|
increases expression | ISO | 5 | 139,493,708 | 139,499,001 | RGD:6480464 | CTD | |
| G | PUS10 | pseudouridylate synthase 10 |
|
affects expression | ISO | 2 | 61,167,548 | 61,245,365 | RGD:6480464 | CTD | |
| G | PVRL3 | poliovirus receptor-related 3 |
|
decreases expression | ISO | 3 | 110,790,606 | 110,913,017 | RGD:6480464 | CTD | |
| G | RAB10 | RAB10, member RAS oncogene family |
|
decreases expression | ISO | 2 | 26,256,729 | 26,360,323 | RGD:6480464 | CTD | |
| G | RAB10 | RAB10, member RAS oncogene family |
|
increases expression | ISO | 2 | 26,256,729 | 26,360,323 | RGD:6480464 | CTD | |
| G | RAB11B | RAB11B, member RAS oncogene family |
|
decreases expression | ISO | 19 | 8,455,205 | 8,469,318 | RGD:6480464 | CTD | |
| G | RAB13 | RAB13, member RAS oncogene family |
|
decreases expression | ISO | 1 | 153,954,127 | 153,958,806 | RGD:6480464 | CTD | |
| G | RAB3D | RAB3D, member RAS oncogene family |
|
affects expression | ISO | 19 | 11,432,722 | 11,450,344 | RGD:6480464 | CTD | |
| G | RAB8B | RAB8B, member RAS oncogene family |
|
increases expression | EXP | 15 | 63,481,728 | 63,559,975 | RGD:6480464 | CTD | |
| G | RAB9A | RAB9A, member RAS oncogene family |
|
multiple interactions | ISO | X | 13,707,240 | 13,727,944 | RGD:6480464 | CTD | |
| G | RABEP2 | rabaptin, RAB GTPase binding effector protein 2 |
|
decreases expression | ISO | 16 | 28,915,742 | 28,936,532 | RGD:6480464 | CTD | |
| G | RALA | v-ral simian leukemia viral oncogene homolog A (ras related) |
|
increases expression | ISO | 7 | 39,663,152 | 39,747,723 | RGD:6480464 | CTD | |
| G | RAN | RAN, member RAS oncogene family |
|
increases expression | ISO | 12 | 131,356,617 | 131,360,826 | RGD:6480464 | CTD | |
| G | RAN | RAN, member RAS oncogene family |
|
multiple interactions | ISO | 12 | 131,356,617 | 131,360,826 | RGD:6480464 | CTD | |
| G | RAN | RAN, member RAS oncogene family |
|
increases expression | ISO | 12 | 131,356,617 | 131,360,826 | RGD:6480464 | CTD | |
| G | RANGAP1 | Ran GTPase activating protein 1 |
|
decreases expression | ISO | 22 | 41,641,615 | 41,682,216 | RGD:6480464 | CTD | |
| G | RBBP4 | retinoblastoma binding protein 4 |
|
multiple interactions | ISO | 1 | 33,116,749 | 33,151,812 | RGD:6480464 | CTD | |
| G | RBBP4 | retinoblastoma binding protein 4 |
|
increases expression | ISO | 1 | 33,116,749 | 33,151,812 | RGD:6480464 | CTD | |
| G | RBPMS | RNA binding protein with multiple splicing |
|
increases expression | ISO | 8 | 30,241,944 | 30,429,734 | RGD:6480464 | CTD | |
| G | RBPMS | RNA binding protein with multiple splicing |
|
affects expression | ISO | 8 | 30,241,944 | 30,429,734 | RGD:6480464 | CTD | |
| G | RCAN1 | regulator of calcineurin 1 |
|
decreases expression | ISO | 21 | 35,888,782 | 35,987,382 | RGD:6480464 | CTD | |
| G | RDH16 | retinol dehydrogenase 16 (all-trans) |
|
decreases expression | ISO | 12 | 57,345,215 | 57,351,418 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression | ISO | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression | ISO | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases expression | ISO | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases expression | ISO | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression | ISO | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RELB | v-rel reticuloendotheliosis viral oncogene homolog B |
|
increases expression | EXP | 19 | 45,504,707 | 45,541,456 | RGD:6480464 | CTD | |
| G | RESP18 | regulated endocrine-specific protein 18 |
|
decreases expression | ISO | 2 | 220,192,131 | 220,197,899 | RGD:6480464 | CTD | |
| G | RFWD2 | ring finger and WD repeat domain 2, E3 ubiquitin protein ligase |
|
increases expression | ISO | 1 | 175,913,967 | 176,176,370 | RGD:6480464 | CTD | |
| G | RHEB | Ras homolog enriched in brain |
|
increases expression | ISO | 7 | 151,163,098 | 151,217,010 | RGD:6480464 | CTD | |
| G | RHOB | ras homolog family member B |
|
multiple interactions | ISO | 2 | 20,646,835 | 20,649,201 | RGD:6480464 | CTD | |
| G | RNF149 | ring finger protein 149 |
|
increases expression | EXP | 2 | 101,892,063 | 101,925,178 | RGD:6480464 | CTD | |
| G | RNPEPL1 | arginyl aminopeptidase (aminopeptidase B)-like 1 |
|
increases expression | ISO | 2 | 241,508,004 | 241,518,149 | RGD:6480464 | CTD | |
| G | ROBO1 | roundabout, axon guidance receptor, homolog 1 (Drosophila) |
|
increases expression | ISO | 3 | 78,646,388 | 79,817,059 | RGD:6480464 | CTD | |
| G | RPL27A | ribosomal protein L27a |
|
decreases expression | ISO | 11 | 8,703,995 | 8,711,419 | RGD:6480464 | CTD | |
| G | RPL3 | ribosomal protein L3 |
|
increases expression | ISO | 22 | 39,708,887 | 39,715,670 | RGD:6480464 | CTD | |
| G | RPL37A | ribosomal protein L37a |
|
decreases expression | ISO | 2 | 217,363,520 | 217,366,190 | RGD:6480464 | CTD | |
| G | RPL9 | ribosomal protein L9 |
|
increases expression | ISO | 4 | 39,455,744 | 39,460,568 | RGD:6480464 | CTD | |
| G | RPS18 | ribosomal protein S18 |
|
increases expression | ISO | 6 | 33,239,852 | 33,244,281 | RGD:6480464 | CTD | |
| G | RPS24 | ribosomal protein S24 |
|
increases expression | ISO | 10 | 79,793,518 | 79,816,571 | RGD:6480464 | CTD | |
| G | RPS3A | ribosomal protein S3A |
|
decreases expression | ISO | 4 | 152,020,725 | 152,025,804 | RGD:6480464 | CTD | |
| G | RPS6KB1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
|
increases expression | ISO | 17 | 57,970,443 | 58,027,787 | RGD:6480464 | CTD | |
| G | RPS8 | ribosomal protein S8 |
|
increases expression | ISO | 1 | 45,241,246 | 45,244,412 | RGD:6480464 | CTD | |
| G | RRAGA | Ras-related GTP binding A |
|
increases expression | ISO | 9 | 19,049,372 | 19,051,023 | RGD:6480464 | CTD | |
| G | RTN4 | reticulon 4 |
|
multiple interactions | ISO | 2 | 55,199,325 | 55,277,734 | RGD:6480464 | CTD | |
| G | RUNX1 | runt-related transcription factor 1 |
|
decreases expression | ISO | 21 | 36,160,098 | 36,421,595 | RGD:6480464 | CTD | |
| G | RXRA | retinoid X receptor, alpha |
|
decreases expression | ISO | 9 | 137,218,316 | 137,332,431 | RGD:6480464 | CTD | |
| G | RXRA | retinoid X receptor, alpha |
|
increases expression | ISO | 9 | 137,218,316 | 137,332,431 | RGD:6480464 | CTD | |
| G | RXRG | retinoid X receptor, gamma |
|
decreases expression | ISO | 1 | 165,370,159 | 165,414,592 | RGD:6480464 | CTD | |
| G | RYR2 | ryanodine receptor 2 (cardiac) |
|
decreases expression | ISO | 1 | 237,205,702 | 237,997,288 | RGD:6480464 | CTD | |
| G | S100A1 | S100 calcium binding protein A1 |
|
decreases expression | ISO | 1 | 153,600,873 | 153,604,512 | RGD:6480464 | CTD | |
| G | S100A10 | S100 calcium binding protein A10 |
|
increases expression | ISO | 1 | 151,955,386 | 151,966,714 | RGD:6480464 | CTD | |
| G | SACM1L | SAC1 suppressor of actin mutations 1-like (yeast) |
|
decreases expression | ISO | 3 | 45,730,754 | 45,786,900 | RGD:6480464 | CTD | |
| G | SAFB | scaffold attachment factor B |
|
decreases expression | ISO | 19 | 5,623,046 | 5,668,489 | RGD:6480464 | CTD | |
| G | SAP30L | SAP30-like |
|
increases expression | ISO | 5 | 153,825,517 | 153,840,613 | RGD:6480464 | CTD | |
| G | SAR1B | SAR1 homolog B (S. cerevisiae) |
|
decreases expression | ISO | 5 | 133,936,839 | 133,968,533 | RGD:6480464 | CTD | |
| G | SDC4 | syndecan 4 |
|
decreases expression | ISO | 20 | 43,953,928 | 43,977,064 | RGD:6480464 | CTD | |
| G | SDC4 | syndecan 4 |
|
decreases expression | ISO | 20 | 43,953,928 | 43,977,064 | RGD:6480464 | CTD | |
| G | SDHC | succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa |
|
affects expression | ISO | 1 | 161,284,166 | 161,334,541 | RGD:6480464 | CTD | |
| G | SELL | selectin L |
|
increases expression | ISO | 1 | 169,659,806 | 169,680,843 | RGD:6480464 | CTD | |
| G | SERBP1 | SERPINE1 mRNA binding protein 1 |
|
increases expression | ISO | 1 | 67,873,493 | 67,896,123 | RGD:6480464 | CTD | |
| G | SERINC1 | serine incorporator 1 |
|
increases expression | ISO | 6 | 122,764,493 | 122,792,952 | RGD:6480464 | CTD | |
| G | SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
decreases expression | ISO | 14 | 94,843,084 | 94,857,029 | RGD:6480464 | CTD | |
| G | SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
|
multiple interactions | ISO | 14 | 95,078,714 | 95,090,390 | RGD:6480464 | CTD | |
| G | SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
|
increases expression | EXP | 6 | 2,832,566 | 2,842,283 | RGD:6480464 | CTD | |
| G | SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions | ISO | 7 | 100,770,370 | 100,782,547 | RGD:6480464 | CTD | |
| G | SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
affects expression | ISO | 7 | 100,770,370 | 100,782,547 | RGD:6480464 | CTD | |
| G | SERPINF1 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
affects expression | ISO | 17 | 1,665,259 | 1,680,859 | RGD:6480464 | CTD | |
| G | SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
|
decreases expression | ISO | 17 | 1,646,130 | 1,658,559 | RGD:6480464 | CTD | |
| G | SESN2 | sestrin 2 |
|
increases expression | EXP | 1 | 28,585,963 | 28,609,002 | RGD:6480464 | CTD | |
| G | SET | SET nuclear oncogene |
|
increases expression | ISO | 9 | 131,445,934 | 131,458,675 | RGD:6480464 | CTD | |
| G | SET | SET nuclear oncogene |
|
multiple interactions | EXP | 9 | 131,445,934 | 131,458,675 | RGD:6480464 | CTD | |
| G | SET | SET nuclear oncogene |
|
affects response to substance | EXP | 9 | 131,445,934 | 131,458,675 | RGD:6480464 | CTD | |
| G | SET | SET nuclear oncogene |
|
increases expression | EXP | 9 | 131,445,934 | 131,458,675 | RGD:6480464 | CTD | |
| G | SF1 | splicing factor 1 |
|
multiple interactions | ISO | 11 | 64,532,076 | 64,546,316 | RGD:6480464 | CTD | |
| G | SFT2D1 | SFT2 domain containing 1 |
|
increases expression | ISO | 6 | 166,733,516 | 166,755,991 | RGD:6480464 | CTD | |
| G | SFT2D1 | SFT2 domain containing 1 |
|
increases expression | ISO | 6 | 166,733,516 | 166,755,991 | RGD:6480464 | CTD | |
| G | SHISA4 | shisa homolog 4 (Xenopus laevis) |
|
affects expression | ISO | 1 | 201,857,797 | 201,861,715 | RGD:6480464 | CTD | |
| G | SIAH2 | siah E3 ubiquitin protein ligase 2 |
|
increases expression | ISO | 3 | 150,458,910 | 150,481,263 | RGD:6480464 | CTD | |
| G | SKI | v-ski sarcoma viral oncogene homolog (avian) |
|
multiple interactions | ISO | 1 | 2,160,134 | 2,241,652 | RGD:6480464 | CTD | |
| G | SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
decreases expression | ISO | 14 | 70,242,552 | 70,264,006 | RGD:6480464 | CTD | |
| G | SLC16A1 | solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
multiple interactions | ISO | 1 | 113,454,469 | 113,498,975 | RGD:6480464 | CTD | |
| G | SLC16A2 | solute carrier family 16, member 2 (thyroid hormone transporter) |
|
affects expression | ISO | X | 73,641,328 | 73,753,764 | RGD:6480464 | CTD | |
| G | SLC16A7 | solute carrier family 16, member 7 (monocarboxylic acid transporter 2) |
|
increases expression | ISO | 12 | 59,989,821 | 60,183,636 | RGD:6480464 | CTD | |
| G | SLC22A5 | solute carrier family 22 (organic cation/carnitine transporter), member 5 |
|
affects expression | ISO | 5 | 131,705,401 | 131,731,306 | RGD:6480464 | CTD | |
| G | SLC22A7 | solute carrier family 22 (organic anion transporter), member 7 |
|
decreases expression | ISO | 6 | 43,265,998 | 43,273,276 | RGD:6480464 | CTD | |
| G | SLC25A15 | solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 |
|
increases expression | ISO | 13 | 41,363,547 | 41,386,596 | RGD:6480464 | CTD | |
| G | SLC25A4 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
affects expression | ISO | 4 | 186,064,417 | 186,071,538 | RGD:6480464 | CTD | |
| G | SLC38A2 | solute carrier family 38, member 2 |
|
increases expression | EXP | 12 | 46,751,971 | 46,766,645 | RGD:6480464 | CTD | |
| G | SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression | ISO | 11 | 62,623,484 | 62,656,355 | RGD:6480464 | CTD | |
| G | SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression | ISO | 11 | 62,623,484 | 62,656,355 | RGD:6480464 | CTD | |
| G | SLC7A11 | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression | EXP | 4 | 139,085,248 | 139,163,503 | RGD:6480464 | CTD | |
| G | SLC9A3R1 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
multiple interactions | ISO | 17 | 72,744,751 | 72,765,499 | RGD:6480464 | CTD | |
| G | SLPI | secretory leukocyte peptidase inhibitor |
|
decreases expression | ISO | 20 | 43,880,879 | 43,883,206 | RGD:6480464 | CTD | |
| G | SMAD2 | SMAD family member 2 |
|
increases expression | ISO | 18 | 45,359,466 | 45,457,517 | RGD:6480464 | CTD | |
| G | SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
|
affects expression | ISO | 7 | 150,936,059 | 150,974,231 | RGD:6480464 | CTD | |
| G | SNRK | SNF related kinase |
|
increases expression | ISO | 3 | 43,328,004 | 43,392,635 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
decreases expression | ISO | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SON | SON DNA binding protein |
|
increases expression | ISO | 21 | 34,915,350 | 34,949,812 | RGD:6480464 | CTD | |
| G | SOS2 | son of sevenless homolog 2 (Drosophila) |
|
multiple interactions | ISO | 14 | 50,583,846 | 50,698,099 | RGD:6480464 | CTD | |
| G | SOX18 | SRY (sex determining region Y)-box 18 |
|
increases expression | ISO | 20 | 62,679,079 | 62,680,979 | RGD:6480464 | CTD | |
| G | SP1 | Sp1 transcription factor |
|
increases expression | ISO | 12 | 53,773,979 | 53,810,230 | RGD:6480464 | CTD | |
| G | SPARC | secreted protein, acidic, cysteine-rich (osteonectin) |
|
multiple interactions | ISO | 5 | 151,040,657 | 151,066,615 | RGD:6480464 | CTD | |
| G | SPARC | secreted protein, acidic, cysteine-rich (osteonectin) |
|
increases expression | ISO | 5 | 151,040,657 | 151,066,615 | RGD:6480464 | CTD | |
| G | SPINT2 | serine peptidase inhibitor, Kunitz type, 2 |
|
multiple interactions | ISO | 19 | 38,755,098 | 38,783,254 | RGD:6480464 | CTD | |
| G | SPP1 | secreted phosphoprotein 1 |
|
multiple interactions | ISO | 4 | 88,896,802 | 88,904,563 | RGD:6480464 | CTD | |
| G | SPP1 | secreted phosphoprotein 1 |
|
increases expression | ISO | 4 | 88,896,802 | 88,904,563 | RGD:6480464 | CTD | |
| G | SQSTM1 | sequestosome 1 |
|
multiple interactions | ISO | 5 | 179,233,388 | 179,265,078 | RGD:6480464 | CTD | |
| G | SRD5A1 | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
decreases expression | ISO | 5 | 6,633,500 | 6,669,675 | RGD:6480464 | CTD | |
| G | SRF | serum response factor (c-fos serum response element-binding transcription factor) |
|
increases expression | ISO | 6 | 43,138,920 | 43,149,244 | RGD:6480464 | CTD | |
| G | SRM | spermidine synthase |
|
increases expression | ISO | 1 | 11,114,649 | 11,120,091 | RGD:6480464 | CTD | |
| G | SRSF3 | serine/arginine-rich splicing factor 3 |
|
decreases expression | ISO | 6 | 36,562,090 | 36,572,244 | RGD:6480464 | CTD | |
| G | SRXN1 | sulfiredoxin 1 |
|
increases expression | ISO | 20 | 627,259 | 633,890 | RGD:6480464 | CTD | |
| G | ST13 | suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) |
|
increases expression | ISO | 22 | 41,220,599 | 41,252,687 | RGD:6480464 | CTD | |
| G | STAT5B | signal transducer and activator of transcription 5B |
|
decreases expression | ISO | 17 | 40,351,195 | 40,428,424 | RGD:6480464 | CTD | |
| G | STOM | stomatin |
|
multiple interactions | ISO | 9 | 124,101,266 | 124,132,582 | RGD:6480464 | CTD | |
| G | STRBP | spermatid perinuclear RNA binding protein |
|
increases expression | ISO | 9 | 125,883,899 | 126,030,855 | RGD:6480464 | CTD | |
| G | STX11 | syntaxin 11 |
|
increases expression | EXP | 6 | 144,471,654 | 144,513,076 | RGD:6480464 | CTD | |
| G | SYT12 | synaptotagmin XII |
|
affects expression | ISO | 11 | 66,790,190 | 66,818,334 | RGD:6480464 | CTD | |
| G | TAF1A | TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa |
|
increases expression | EXP | 1 | 222,731,244 | 222,763,275 | RGD:6480464 | CTD | |
| G | TAF1B | TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa |
|
increases expression | EXP | 2 | 9,983,571 | 10,074,545 | RGD:6480464 | CTD | |
| G | TCP1 | t-complex 1 |
|
multiple interactions | ISO | 6 | 160,199,530 | 160,210,735 | RGD:6480464 | CTD | |
| G | TCP1 | t-complex 1 |
|
increases expression | ISO | 6 | 160,199,530 | 160,210,735 | RGD:6480464 | CTD | |
| G | TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
|
increases expression | ISO | 6 | 10,396,916 | 10,419,797 | RGD:6480464 | CTD | |
| G | TFDP1 | transcription factor Dp-1 |
|
decreases expression | ISO | 13 | 114,239,003 | 114,295,788 | RGD:6480464 | CTD | |
| G | TFF3 | trefoil factor 3 (intestinal) |
|
decreases expression | ISO | 21 | 43,731,777 | 43,735,706 | RGD:6480464 | CTD | |
| G | TGFB1 | transforming growth factor, beta 1 |
|
decreases expression | ISO | 19 | 41,836,812 | 41,859,831 | RGD:6480464 | CTD | |
| G | TGFB2 | transforming growth factor, beta 2 |
|
increases expression | ISO | 1 | 218,518,676 | 218,617,961 | RGD:6480464 | CTD | |
| G | TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
|
multiple interactions | ISO | 1 | 43,766,566 | 43,788,781 | RGD:6480464 | CTD | |
| G | TIMM10B | translocase of inner mitochondrial membrane 10 homolog B (yeast) |
|
increases expression | ISO | 11 | 6,502,677 | 6,505,911 | RGD:6480464 | CTD | |
| G | TKT | transketolase |
|
decreases expression | ISO | 3 | 53,258,723 | 53,290,130 | RGD:6480464 | CTD | |
| G | TM7SF2 | transmembrane 7 superfamily member 2 |
|
affects expression | ISO | 11 | 64,879,341 | 64,883,707 | RGD:6480464 | CTD | |
| G | TMED10 | transmembrane emp24-like trafficking protein 10 (yeast) |
|
decreases expression | ISO | 14 | 75,598,171 | 75,643,349 | RGD:6480464 | CTD | |
| G | TMEM132A | transmembrane protein 132A |
|
affects expression | ISO | 11 | 60,691,913 | 60,704,631 | RGD:6480464 | CTD | |
| G | TMEM176A | transmembrane protein 176A |
|
increases expression | ISO | 7 | 150,497,854 | 150,502,208 | RGD:6480464 | CTD | |
| G | TMEM259 | transmembrane protein 259 |
|
increases expression | ISO | 19 | 1,009,650 | 1,021,141 | RGD:6480464 | CTD | |
| G | TMEM5 | transmembrane protein 5 |
|
affects expression | ISO | 12 | 64,173,637 | 64,202,887 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
decreases expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
decreases expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
|
increases expression | EXP | 6 | 138,188,325 | 138,204,451 | RGD:6480464 | CTD | |
| G | TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A |
|
increases expression | ISO | 16 | 3,070,313 | 3,072,384 | RGD:6480464 | CTD | |
| G | TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A |
|
multiple interactions | ISO | 12 | 6,437,923 | 6,451,283 | RGD:6480464 | CTD | |
| G | TNFRSF8 | tumor necrosis factor receptor superfamily, member 8 |
|
decreases expression | EXP | 1 | 12,123,434 | 12,204,264 | RGD:6480464 | CTD | |
| G | TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 |
|
multiple interactions | ISO | 17 | 7,452,375 | 7,461,207 | RGD:6480464 | CTD | |
| G | TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 |
|
increases expression | ISO | 17 | 7,452,375 | 7,461,207 | RGD:6480464 | CTD | |
| G | TOB1 | transducer of ERBB2, 1 |
|
multiple interactions | ISO | 17 | 48,939,584 | 48,945,339 | RGD:6480464 | CTD | |
| G | TOB1 | transducer of ERBB2, 1 |
|
increases expression | ISO | 17 | 48,939,584 | 48,945,339 | RGD:6480464 | CTD | |
| G | TP53 | tumor protein p53 |
|
increases expression | EXP | 17 | 7,571,720 | 7,590,868 | RGD:6480464 | CTD | |
| G | TPI1 | triosephosphate isomerase 1 |
|
increases expression | ISO | 12 | 6,976,584 | 6,980,110 | RGD:6480464 | CTD | |
| G | TPP2 | tripeptidyl peptidase II |
|
increases expression | ISO | 13 | 103,249,286 | 103,331,524 | RGD:6480464 | CTD | |
| G | TRAF3 | TNF receptor-associated factor 3 |
|
increases expression | ISO | 14 | 103,243,816 | 103,377,837 | RGD:6480464 | CTD | |
| G | TRAP1 | TNF receptor-associated protein 1 |
|
affects expression | ISO | 16 | 3,708,038 | 3,767,598 | RGD:6480464 | CTD | |
| G | TRIM28 | tripartite motif containing 28 |
|
increases expression | ISO | 19 | 59,055,836 | 59,062,082 | RGD:6480464 | CTD | |
| G | TRIP12 | thyroid hormone receptor interactor 12 |
|
decreases expression | ISO | 2 | 230,631,930 | 230,786,655 | RGD:6480464 | CTD | |
| G | TSKU | tsukushi, small leucine rich proteoglycan |
|
decreases expression | ISO | 11 | 76,493,357 | 76,509,198 | RGD:6480464 | CTD | |
| G | TSPAN13 | tetraspanin 13 |
|
affects expression | ISO | 7 | 16,793,351 | 16,824,161 | RGD:6480464 | CTD | |
| G | TSPYL1 | TSPY-like 1 |
|
decreases expression | ISO | 6 | 116,596,022 | 116,601,280 | RGD:6480464 | CTD | |
| G | TTC39C | tetratricopeptide repeat domain 39C |
|
affects expression | ISO | 18 | 21,572,737 | 21,715,574 | RGD:6480464 | CTD | |
| G | TTPA | tocopherol (alpha) transfer protein |
|
increases expression | ISO | 8 | 63,972,047 | 63,998,612 | RGD:6480464 | CTD | |
| G | TXNIP | thioredoxin interacting protein |
|
multiple interactions | ISO | 1 | 145,438,462 | 145,442,635 | RGD:6480464 | CTD | |
| G | TXNL1 | thioredoxin-like 1 |
|
increases expression | ISO | 18 | 54,270,053 | 54,305,920 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases expression | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | UBE2D3 | ubiquitin-conjugating enzyme E2D 3 |
|
increases expression | ISO | 4 | 103,717,133 | 103,790,032 | RGD:6480464 | CTD | |
| G | UBE3A | ubiquitin protein ligase E3A |
|
increases expression | ISO | 15 | 25,582,396 | 25,684,175 | RGD:6480464 | CTD | |
| G | UBFD1 | ubiquitin family domain containing 1 |
|
increases expression | ISO | 16 | 23,568,862 | 23,585,710 | RGD:6480464 | CTD | |
| G | UCK1 | uridine-cytidine kinase 1 |
|
increases expression | ISO | 9 | 134,399,183 | 134,406,662 | RGD:6480464 | CTD | |
| G | UGT1A1 | UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression | ISO | 2 | 234,668,919 | 234,681,945 | RGD:6480464 | CTD | |
| G | UGT2A1 | UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus |
|
increases expression | ISO | 4 | 70,454,135 | 70,518,967 | RGD:6480464 | CTD | |
| G | UPP2 | uridine phosphorylase 2 |
|
decreases expression | ISO | 2 | 158,851,691 | 158,992,666 | RGD:6480464 | CTD | |
| G | USP14 | ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) |
|
affects expression | ISO | 18 | 158,483 | 213,739 | RGD:6480464 | CTD | |
| G | USP18 | ubiquitin specific peptidase 18 |
|
increases expression | EXP | 22 | 18,632,758 | 18,660,164 | RGD:6480464 | CTD | |
| G | USP33 | ubiquitin specific peptidase 33 |
|
decreases expression | ISO | 1 | 78,161,672 | 78,225,564 | RGD:6480464 | CTD | |
| G | VAV1 | vav 1 guanine nucleotide exchange factor |
|
multiple interactions | ISO | 19 | 6,772,679 | 6,857,377 | RGD:6480464 | CTD | |
| G | VCP | valosin containing protein |
|
affects expression | ISO | 9 | 35,056,065 | 35,072,739 | RGD:6480464 | CTD | |
| G | VHL | von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
increases mutagenesis | EXP | 3 | 10,183,319 | 10,195,354 | RGD:6480464 | CTD | |
| G | VHL | von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
increases mutagenesis | EXP | 3 | 10,183,319 | 10,195,354 | RGD:6480464 | CTD | |
| G | VIM | vimentin |
|
decreases expression | ISO | 10 | 17,270,258 | 17,279,592 | RGD:6480464 | CTD | |
| G | VIM | vimentin |
|
increases expression | ISO | 10 | 17,270,258 | 17,279,592 | RGD:6480464 | CTD | |
| G | VNN1 | vanin 1 |
|
increases expression | ISO | 6 | 133,001,997 | 133,035,194 | RGD:6480464 | CTD | |
| G | VNN1 | vanin 1 |
|
increases expression | ISO | 6 | 133,001,997 | 133,035,194 | RGD:6480464 | CTD | |
| G | VPS25 | vacuolar protein sorting 25 homolog (S. cerevisiae) |
|
increases expression | ISO | 17 | 40,925,454 | 40,931,617 | RGD:6480464 | CTD | |
| G | VWF | von Willebrand factor |
|
decreases expression | ISO | 12 | 6,058,040 | 6,233,836 | RGD:6480464 | CTD | |
| G | WDR92 | WD repeat domain 92 |
|
increases expression | ISO | 2 | 68,357,281 | 68,384,692 | RGD:6480464 | CTD | |
| G | WWP1 | WW domain containing E3 ubiquitin protein ligase 1 |
|
decreases expression | ISO | 8 | 87,354,994 | 87,480,181 | RGD:6480464 | CTD | |
| G | XBP1 | X-box binding protein 1 |
|
increases expression | EXP | 22 | 29,190,548 | 29,196,560 | RGD:6480464 | CTD | |
| G | YAP1 | Yes-associated protein 1 |
|
decreases expression | ISO | 11 | 101,981,192 | 102,104,154 | RGD:6480464 | CTD | |
| G | YIPF5 | Yip1 domain family, member 5 |
|
increases expression | ISO | 5 | 143,537,726 | 143,550,278 | RGD:6480464 | CTD | |
| G | YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
multiple interactions | ISO | 2 | 9,724,106 | 9,771,106 | RGD:6480464 | CTD | |
| G | ZBTB20 | zinc finger and BTB domain containing 20 |
|
increases expression | ISO | 3 | 114,056,941 | 114,866,127 | RGD:6480464 | CTD | |
| G | ZC3HAV1 | zinc finger CCCH-type, antiviral 1 |
|
increases expression | EXP | 7 | 138,728,266 | 138,794,465 | RGD:6480464 | CTD | |
| G | ZCCHC2 | zinc finger, CCHC domain containing 2 |
|
increases expression | EXP | 18 | 60,190,658 | 60,245,818 | RGD:6480464 | CTD | |
| G | ZFP36 | ZFP36 ring finger protein |
|
decreases expression | ISO | 19 | 39,897,487 | 39,900,052 | RGD:6480464 | CTD | |
| G | ZFPM1 | zinc finger protein, FOG family member 1 |
|
increases expression | ISO | 16 | 88,520,014 | 88,601,574 | RGD:6480464 | CTD | |
| G | ZHX2 | zinc fingers and homeoboxes 2 |
|
decreases expression | ISO | 8 | 123,793,901 | 123,986,755 | RGD:6480464 | CTD | |
| G | ZNF394 | zinc finger protein 394 |
|
decreases expression | ISO | 7 | 99,090,854 | 99,097,877 | RGD:6480464 | CTD | |
| G | ZNRF2 | zinc and ring finger 2 |
|
increases expression | ISO | 7 | 30,323,923 | 30,407,308 | RGD:6480464 | CTD | |
| G | ZWINT | ZW10 interactor, kinetochore protein |
|
increases expression | ISO | 10 | 58,117,199 | 58,121,034 | RGD:6480464 | CTD | |
| G | ZWINT | ZW10 interactor, kinetochore protein |
|
increases expression | ISO | 10 | 58,117,199 | 58,121,034 | RGD:6480464 | CTD | |
Term paths to the root
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term